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SUMMARY 
Sudden infant death syndrome (SIDS) is the leading cause of infant death in the post-neonatal stage 
in developing and developed countries. A diagnosis of SIDS is made after medico-legal investigations 
fail to demonstrate an adequate cause of death in sudden unexpected death in infancy (SUDI) cases 
and SIDS is diagnosed in over 60% of SUDI cases. The peak incidence of SUDI is observed when 
infants are aged between two to four months. It is also at this stage that infants lose their maternally 
acquired immunity against infections. During medico-legal investigations in SUDI cases, viruses and 
bacteria have been confirmed, although none of them was consistently and exclusively associated 
with SUDI to date. Furthermore, viral respiratory symptoms are reported in 44% of SUDI cases, but 
the exact role they play in the events leading up to the death of the infant remains unknown. Viral 
infections can either facilitate easier bacterial colonisation of the respiratory system or induce an 
unregulated immune response through the release of cytokines and chemokines (immune biomarkers) 
that lead to formation of immune complexes in lungs and other respiratory organs. This could result 
in the loss of functionality and ultimately death of the infant. The role played by viruses and the 
interaction of the immune system in the events leading to SIDI therefore require further investigation 
to get a clearer understanding.  
Objectives: The first aim of this cross-sectional, descriptive study was to characterise the respiratory 
viruses observed in SUDI cases investigations at the Tygerberg Medico-Legal Mortuary using the 
Seeplex RV15 ACE detection multiplex PCR kit. The multiplex PCR viral detection results were 
compared to routine shell vial culture results to determine the superior viral detection method. The 
second aim was to assess 16 target immune biomarkers as indicators of infection or inflammation 
prior to or at the time of death of an infant.  
Methods: Samples were collected from 183 SUDI cases admitted to the Tygerberg Medico-Legal 
Mortuary between July 2015 and June 2016. Swabs collected from the trachea and left and right lungs 
were collected for multiplex PCR detection of 15 respiratory viruses. These viral targets were human 
adenovirus, human bocavirus, human coronavirus 229E/NL63, OC43, human enterovirus, influenza 
A and B, human metapneumovirus, human parainfluenza 1-4, respiratory syncytial virus A and B and 
human rhinovirus A/B/C. Serum was also collected for immune biomarker testing. Tissue from both 
lungs were collected for shell vial culture and blood was collected for HIV 1/2 antibody testing. 
Microbiology routine testing included culture of heart, left and right lung swab samples. 
Results: The gender distribution of infants in this study was not consistent with literature. There were 
93 (50.8%) females and 90 (49.2%) males, although males have been identified as being at a greater 
Stellenbosch University  https://scholar.sun.ac.za
 
 
iv 
risk of SUDI than females. However, other socio-demographic risk factors for SUDI, such as the 
greatest risk of death being at age two to four months were consistent with literature. The detection 
of viruses by multiplex PCR proved to be superior to SVC as the former detected viruses in more 
cases than the latter. The most commonly detected virus by multiplex PCR was human Rhinovirus 
A/B/C, which was detected in 65 (35.5%) of the 183 cases tested. Adenovirus was the second most 
frequently detected virus as it was present in 18 (12.6%) of the cases tested. Parainfluenza 3, 
Enterovirus and RSV B were detected in 10 (5.5%), 9 (4.9%) and 7 (3.8%) cases respectively. Human 
metapneumovirus was not detected at all by either assay.  
The serum concentrations of CRP and IL-6 were significantly elevated in the serum of SUDI cases 
where infection was the cause death compared to cases that were diagnosed as SIDS. However, levels 
of IL-18 were significantly reduced in the serum of SUDI cases where infection was the cause of 
death compared to cases with a final cause of death classification of SIDS.   
Conclusion: It is possible to change the cause of death from SIDS to infection if serum immune 
biomarker results and multiplex PCR are used in addition to tissue histology. The current study 
showed that serum CRP, IL-6 and IL-18 levels can possibly be regarded as candidates for use as 
indicators of infectious death and these findings need to be further investigated in larger study cohorts 
and over longer study periods. 
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CHAPTER 1: INTRODUCTION 
Dwight Eisenhower, the 34th president of the United States of America (USA) once said about the 
loss of a child, “There is no tragedy in life like the death of a child. Things never get back to the way 
they were.” In this statement, he summarised a whirlwind of emotions that follow the loss of a loved 
one in their formative years and the life-changing impact it has on those that remain behind.  
Quite a number of factors can contribute towards the death of infants. The Centre for Disease Control 
and Prevention (CDC) identified among others, Sudden Infant Death Syndrome (SIDS) as one of the 
leading causes of death in infancy. Prematurity, SIDS, birth defects, complications in pregnancy and 
suffocation alone were responsible for more than 55% of infant deaths in the USA in 2011. In the 
District of Columbia and the rest of the USA, SIDS was the leading cause of infant death in the post-
neonatal period (Heron, 2015), fuelling more investigative interest in SIDS and the dynamics 
surrounding it (Bajanowski et al., 2007). 
Initially, SIDS was defined as the sudden death of any infant or young child, which is unexpected by 
history, and in which a thorough post-mortem (PM) examination fails to demonstrate an adequate 
cause of death (COD). This definition was widely referred to as the “Seattle Definition” of SIDS 
(Beckwith, 2003). Over the years, the definition of SIDS has evolved with the emergence of new 
information from various fields of study. Some twenty years after formulation of the original SIDS 
definition, the National Institute of Child Health and Human Development (NICHD) set up a panel 
of experts to further clarify the definition. The panel ultimately made a few changes to the original 
definition. The concept of SIDS was now limited to death of infants under the age of one year and 
investigation of the death scene formed a part of an inquest into an infant’s death (Krous, 2010). The 
most recently documented definition of SIDS is the 2004 ‘San Diego Definition’. This defines SIDS 
as the sudden and unexpected death of an infant under one year of age, with onset of the lethal episode 
apparently occurring during sleep, which remains unexplained after a thorough investigation, 
including conducting a complete autopsy, and review of the circumstances of death and the clinical 
history (Krous et al., 2004). Making a SIDS diagnosis is only possible when there is no evidence of 
an adequate COD and it is for this reason that it is referred to as a diagnosis of exclusion (Blackwell 
et al., 2015). The terms SIDS and SUDI (Sudden Unexpected Death in infancy) are being used 
interchangeably in literature although they do not necessarily mean the same. It is important to note 
that SUDI is an all-encompassing term describing all cases of sudden and infant unexpected death 
before any investigation is conducted. As such, SIDS is a sub-category of SUDI. 
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Various theories on the possible causes of SIDS have been proposed over the past five decades, 
including the possible role of respiratory viruses, such as respiratory syncytial virus (RSV), human 
adenovirus (HAdV), influenza virus, human coronavirus (HCoV), human parainfluenza virus (HPIV) 
and human metapneumovirus (HMPV). Although the involvement of these viruses in SIDS has been 
a subject of intense investigative research, their exact role remains a mystery, as there has been no 
consistent and direct link between any single virus and sudden infant death (Raza & Blackwell, 1999).  
1.1 Investigations into SUDI cases in South Africa 
Medico-legal SUDI case investigations are conducted in most developed countries and a handful 
other developing countries (du Toit-Prinsloo et al., 2013). However, the detail of such investigations 
frequently depends on the available resources at particular institutions (du Toit-Prinsloo et al., 2011). 
According to the South African Inquests Act (Act 58 of 1959), all unnatural deaths, including SUDI, 
must be investigated to ascertain the COD. At Tygerberg Medico-Legal Mortuary, all SUDI cases are 
investigated as required by the Act. However, the way in which these investigations are conducted 
varies significantly among institutions. Du Toit-Prinsloo and colleagues (2011) investigated SUDI 
cases at the Medico-Legal Mortuaries of Tygerberg (Cape Town) and Pretoria and they identified 
differences in investigation protocols and ancillary investigations conducted. However, despite this, 
South Africa has no nationally accepted, standardised SUDI case investigation protocol and the 
Tygerberg Medico-Legal Mortuary utilises an institutional investigation protocol. The information 
generated from these investigations at different medico-legal centres is therefore difficult, if not 
impossible to compare. As more research emerges in the field, some of the findings might be valuable 
in establishing regional and national standard SUDI case investigation protocols. A standardised 
SUDI investigation protocol will allow for the generation of a database that can serve as a reference 
point to identify possible trends in SUDI cases in South Africa and may lead to steps being taken to 
address the problem. 
In addition to a thorough autopsy and review of the medical history of the infant, investigations into 
SUDI cases also include an array of laboratory tests. The gold standard in these investigations is 
histological examination of lung and liver tissue, although histology might fail at times to determine 
the exact cause in sudden infant death. Ancillary investigations can include the use of viral culture 
techniques, such as shell vial cultures (SVC) to detect viruses in lung and liver tissue and 
microbiological culture of swabs taken from the lungs, liver and heart to detect bacteria and other 
microorganisms. However, an increased PM interval (PMI) in some cases often results in the loss of 
viral viability in tissue samples prepared for SVC. As such, most viral culture results are negative for 
any of the target respiratory viruses routinely being tested for.  
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1.2 Diagnostic testing of respiratory viruses 
Viral detection methods have evolved over the years, as novel viruses continue to emerge due to 
zoonotic transmission as well as evolution and identification of new viral strains. These methods 
involve viral culture in specific cell lines, detection of viral components (antigens or nucleic acids), 
as well as detection of antiviral antibodies. However, each assay has its own shortcomings and can 
as such limit its usefulness under specific circumstances.  
1.2.1 Viral culture 
RSV, Influenza, PIV and HAdV are generally diagnosed using viral culture techniques (van de Pol 
et al., 2007). This technique involves the inoculation of viruses into cell lines and observing 
cytopathic effects (CPE), such as syncytia formation, lysis of cells and cell rounding that signifies the 
presence of the virus in cells (Datta et al., 2015). The use of immunofluorescence further assists in 
identifying the virus responsible for the CPE, while further confirmatory tests, such as tests for acid 
lability, are used to distinguish between human rhinoviruses (HRV) and human enteroviruses (HEV) 
(van Elden et al., 2002). However, viral culture is laborious and time consuming and some viruses, 
such as human bocavirus (HBoV), HCoV, HRV and HMPV, can be difficult to culture (Freymuth et 
al., 2006; Burns et al., 2012). This has led to the implementation of more sensitive and rapid viral 
detection techniques. 
1.2.2 Antigen and antibody based detection 
The detection of viral antigens or antibodies specific for that virus in patient samples confirms the 
presence of that virus at a certain point in the patient’s life. One method that utilises this principle is 
the enzyme linked immunosorbent assay (ELISA). Targeting of antigens is generally in the acute 
stage of infection, while antibody targeting is useful at later stages once seroconversion has taken 
place. Several respiratory viruses, such as RSV, have been detected in nasopharyngeal secretions by 
identifying virus-specific antigens by using virus-specific antibodies in an antigen capture enzyme 
immunoassay (Abels et al., 2001). In a study to detect RSV antigen in nasopharyngeal aspirates 
(NPA) obtained from hospitalised paediatric patients with suspected respiratory viral infection, 
ELISA proved to be insensitive in cases where the viral load was low when compared to reverse 
transcriptase polymerase chain reaction (PCR) technology, which was highly sensitive (Mentel et al., 
2005).  
1.2.3 Nucleic acid amplification  
Nucleic acid amplification techniques have greatly improved the sensitivity and specificity for 
identifying respiratory viruses in patient samples (Abels et al., 2001; Jansen et al., 2011). These PCR 
Stellenbosch University  https://scholar.sun.ac.za
 4 
assays are also rapid and have a much faster turnaround time than viral culture. However, this raises 
the question of whether or not the mere detection of a particular virus can be regarded as clinically 
relevant. The conduction of PCR to detect respiratory viruses has been on symptomatic individuals 
rather than asymptomatic. In a case-control study on symptomatic and asymptomatic children 
conducted by Jansen et al., (2011), it was shown that unlike HRV, which was present in both 
symptomatic and asymptomatic children, RSV was more often detected in symptomatic than 
asymptomatic children. Children with respiratory symptoms showed an association between the 
presence of RSV confirmed with PCR and the clinical picture observed (Jansen et al., 2011).  
After the conduction of medico-legal investigations, more than two thirds of the SUDI cases remain 
without a definite COD and are therefore classified as SIDS (Dempers et al., 2016). With viral culture 
methods alone, it is often difficult to diagnose infection, as viruses tend to lose viability after death, 
rendering SVC unable to produce positive results. However, if immune biomarker testing is used in 
parallel with tissue histology and multiplex PCR, an infectious aetiology in SIDS can be identified 
more often and with greater confidence. Consequently, some of the SUDI cases in which a SIDS 
diagnosis is made can actually be due to infection if properly diagnosed.  
This was in part the reason we hypothesised that serum levels of immune markers in SUDI cases 
indicate an infection or inflammatory event prior to the sudden death of an infant. 
1.3 Routine investigation of SUDI cases 
At the time of this research, routine SUDI case investigations at the Tygerberg Medico-Legal 
Mortuary included human immunodeficiency virus (HIV) 1/2 antibody testing, centrifugation-
enhanced SVC of lung and liver tissue, microbiological culture of swabs taken from the left lung, 
heart and liver, as well as histological examination of haematoxylin and eosin (H&E) stained tissue 
sections.  
HIV 1/2 antibody testing is conducted on serum using a rapid, point-of-care ELISA based kit. 
However, the main limitation of conducting antibody tests in infants under the age of one year is the 
high percentage of false positive results due to the presence of maternal immunoglobulin (Ig) G. 
A centrifugation-enhanced SVC method is used to detect viruses like HMPV, Cytomegalovirus 
(CMV), Influenza A and B, HAdV, RSV and HPIV 1-3 in lung and liver tissue. Different cell lines 
were used to culture different viruses and a commercial respiratory virus immunofluorescence assay 
was used to confirm the results. However, viruses from PM samples generally lose viability during 
the PMI and as such rarely produced positive viral culture results.  
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Microbiological swabs from the left lung, heart and the liver are inoculated onto MacConkey, blood 
and chocolate agar culture plates to detect bacteria that might have been present in these organs prior 
to or at the time of death of the infant. Bacteria such as Staphylococcus (Staph) aureus, Haemophilus 
influenzae, Streptococcus (Strep) pneumoniae and Strep pyogenes were expected to be present due to 
prior detection in some sudden infant death investigations (Forsyth, 1999). 
Lung tissue is collected during the autopsy and stored in 10% formalin. It is then processed, embedded 
in paraffin wax, cut with a microtome and fixed to microscope slides. The slides are stained with 
H&E and evaluated under a microscope by forensic pathologists. Pathological and morphological 
changes (severity of tissue inflammation) were noted, including those that might be indicative of an 
infection or a prior inflammatory event.  
1.4 Alternative molecular testing 
Nucleic acid amplification tests (NAATs), such as the Seeplex RV15 ACE Multiplex PCR, which 
target HAdV, HBoV, HCoV, HEV, human influenza virus, HMPV, HPIV 1-4, RSV and HRV can be 
used to detect viral nucleic acid in tissue. However, detection of viral nucleic acid with multiplex 
PCR assay alone does not indicate involvement of the virus in the events leading to the death of the 
infant.  
1.5 Testing for immune biomarkers in SIDS 
Some studies proposed an improper immune response to seemingly harmless respiratory viruses, 
aggravated by an uncontrolled release of cytokines and chemokines, as a possible role player in the 
events leading up to the sudden death of an infant. After the immune response is complete, cytokines 
and chemokines remain in the circulation at elevated levels for several days, such as C-reactive 
protein (CRP) (Uhlin-Hansen, 2001). As such, they can be a target for testing to indicate a prior 
immune or inflammatory event in the moments leading up to the death of an infant. 
There is a paucity of data for normal serum cytokine levels in infants and although biomarker testing 
in serum or cerebrospinal fluid (CSF) from SUDI cases has been ongoing in developed countries 
around the world (Vennemann et al., 2012), no such information is available for South Africa. It was 
therefore worthwhile to explore the levels of 16 immune biomarkers of infection and inflammation 
in serum from SUDI cases as a possible indicator of infection prior to or at the time of death of the 
infants. Correlation of these immunology results with the histological picture of the lungs should 
contribute towards deciding the value of immunological testing and PCR screening in identifying a 
possible infection or inflammatory event in SUDI cases.  
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Additionally, comparison of culture and molecular-based screening methods for respiratory viruses 
should also contribute towards the establishment of a standardised, nationally accepted SUDI case 
investigation protocol for South Africa concerning the selection of viruses to be screened for and the 
best laboratory method to be used. 
1.6 South African SIDS studies 
Although SIDS remains one of the leading causes of death in the post-neonatal stage in developed 
and developing countries (Blackwell et al., 2015), literature searches on PubMed and Google Scholar 
for studies conducted on SIDS in South Africa did not return many articles. This is in direct contrast 
to countries like USA, Germany, New Zealand and the United Kingdom where a lot of research are 
continuously being done on SIDS (Bajanowski et al., 2003; Fernandez-Rodriguez et al., 2006; 
Alvarez-Lafuente et al., 2008; Weber et al., 2008). More research on sudden infant death will add to 
better understanding of the pathogenesis of SIDS, thus paving the way forward for better management 
and prevention where possible. Solid, research-based evidence will add credibility in the initiation of 
education programmes and policy changes.  
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CHAPTER 2: LITERATURE REVIEW 
2.1 Child and infant mortality 
In September 2000, world leaders attended a summit held at the United Nations (UN) headquarters 
in New York to discuss possible ways in which the UN would play a role in improving the quality of 
life for the less privileged in underdeveloped countries. Eight goals were set and earmarked for 
achievement by the year 2015. The summit gave rise to what is known today as the Millennium 
Development Goals (MDGs). While other MDGs targeted the promotion of gender equality and 
combating malaria, HIV and Acquired Immunodeficiency Syndrome (AIDS), etc., the fourth MDG 
(MDG4) was set to target the reduction of child mortality from 1990 to 2015 by over 65% as outlined 
in the 2014 United Nations MDG Report1. 
The two markers identified for child mortality were the under-five mortality rate and infant mortality 
rate. The World Health Organisation (WHO) defines the under-five mortality rate as the number of 
deaths of children under the age of five per 1 000 live births. Infant mortality rate is defined as the 
number of infants dying under the age of one year per 1 000 live births. Global Health Observatory 
(GHO) data from the WHO shows a global decline during a 13 year period (2000-2013) in the number 
of children that are most likely to die before the age of five per 1 000 live births (Figures 2.1 and 2.2).  
Despite various efforts put into achieving MDG4, the set target is quite a long way off from 
achievement and child and infant mortality remain global problems in both developing and developed 
countries (UN Millennium Development Goals Report, 2014).  
2.2 Evolution of the SIDS definition 
Ever since Bruce Beckwith and his colleagues coined the term “sudden infant death syndrome” in 
1969, there has been much controversy surrounding the subject (Beckwith, 1970; Bajanowski et al., 
2006). 
Since the beginning of time, the death of a child or an infant has been an ever-present reality. In the 
Bible, there is an account of one of the earliest cases of sudden and unexpected infant death in 1 Kings 
3:19, where a mother lost her son during the night because she laid on him. 
                                                 
1 http://www.un.org/millenniumgoals/2014%20MDG%20report/MDG%202014%20English%20web.pdf 
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Figure 2.1 Under-five mortality rate (probability of dying by age 5 per 1000 live births), 20002 
 
 
Figure 2.2 Under-five mortality rate (probability of dying by age 5 per 1000 live births), 20133 
                                                 
2 http://gamapserver.who.int/mapLibrary/Files/Maps/global_underfivemortality_2000.png 
3 http://gamapserver.who.int/mapLibrary/Files/Maps/global_underfivemortality_2013.png 
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2.2.1 The San Diego Definition and classification of death 
Being the most recent definition of SIDS, the San Diego definition of 2004 is widely used to classify 
SIDS cases. Different sub-categories of SIDS exist and cases are classified into these sub-categories 
based on the investigations conducted, as well as the findings of those investigations as shown below 
(Bajanowski et al., 2006). 
Category IA SIDS 
SIDS cases that meet any of the following criteria: 
• Infants older than 21 days, but less than nine months old at time of death where investigation of 
the death scene provided no explanation of death and pathological findings observed during 
autopsy were not lethal. 
• Infants with a normal clinical history and slept in a safe environment with autopsy showing no 
evidence of any unexplained trauma, abuse, neglect or unintentional injury. 
• A full term infant (>37 weeks) who died in the absence of any evidence of an accident and autopsy 
showed no substantial thymic stress. 
• An infant who grew and developed normally and toxicology, radiology, microbiology, vitreous 
chemistry and metabolic screening were negative at autopsy. 
• An infant from a family where there was no similar death in siblings or relatives. 
Category IB SIDS 
SIDS cases that meet any of the following criteria: 
• Full term infants older than 21 days, but less than nine months old at time of death with a normal 
clinical history, growth and development and from a family where there was no similar death in 
siblings or relatives. There was no death scene investigation and at autopsy, there was no 
observation of lethal pathological findings, unexplained trauma, abuse, neglect or unintentional 
injury, substantial thymic stress and toxicology, radiology, microbiology, vitreous chemistry and 
metabolic screening were negative. 
• Full term infants older than 21 days, but less than nine months old at time of death with a normal 
clinical history, growth and development and from a family where there was no similar death in 
siblings or relatives. There was no death scene investigation and one or more of toxicology, 
radiology, microbiology, vitreous chemistry and metabolic screening were not done at autopsy. 
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Category II SIDS 
SIDS cases that meet any of the following criteria: 
• Infants whose clinical history at time of death differs from those in Category I SIDS: mechanical 
asphyxia or suffocation by overlaying was not determined with certainty as the circumstance of 
death. At autopsy, there was no observation of lethal pathological findings, unexplained trauma, 
abuse, neglect or unintentional injury, substantial thymic stress and toxicology, radiology, 
microbiology, vitreous chemistry and metabolic screening were negative or there was no 
conduction of one of the tests. 
• Infants whose ages at the time of death ranged from 0-21 days or 270-365 days. At autopsy, 
abnormal growth and development were not thought to have contributed to death. 
• Infants whose neonatal/perinatal conditions have resolved by the time of death and at autopsy, 
marked inflammatory changes or abnormalities are deemed insufficient to cause death. 
• Infants from a family where there has been similar deaths in siblings or near relatives. 
Unclassified Sudden Infant Death (USID) 
SIDS cases that meet any of the following criteria: 
• Infants whose clinical history does not meet criteria for classification into Category I and II SIDS; 
alternative diagnoses of natural or unnatural death are equivocal and an autopsy was not 
performed. 
South Africa, being a developing country, does not have readily available financial resources. As 
such, and as per the San Diego definition of SIDS, cases diagnosed as SIDS in South Africa are 
classified as Category IB SIDS where death scene investigation and other supplementary tests are not 
conducted (du Toit-Prinsloo et al., 2013). 
A case in which an apparently healthy infant under the age of one year dies suddenly and 
unexpectedly is described as SUDI regardless of the COD being explained or not (Weber & Sebire, 
2009). Various medico-legal investigations including conduction of a complete autopsy, review of 
infant’s medical history and death scene investigation are conducted to determine the COD in SUDI 
cases (Figure 2.3) and where investigations fail to determine the COD, the cases are referred to as 
SIDS (Dempers et al., 2016). It is for this reason that in reference to SIDS, the term ‘diagnosis of 
exclusion’ is sometimes used (Krous et al., 2004; Blackwell et al., 2015). However, despite 
conduction of thorough medico-legal investigations, the COD in 50-80% of SUDI cases remains 
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unknown (Dempers et al., 2016). As such, more than half of SUDI cases have a final COD 
classification of SIDS. 
 
Figure 2.3 Flowchart indicating the investigation of SUDI cases to assign the COD classification to 
a case 
2.3 SUDI and SIDS 
For the last half a century or so, use of the terms SIDS and SUDI has been interchangeable. The use 
of either term has been largely dependent on the geographical location of the group conducting the 
research and reporting the results. A potential problem arising from this inconsistency in reporting 
results is the inability to compare data reliably between countries or institutions that reported cases 
differently. Differences in the definitions used to classify SIDS cases lead to misleading variations in 
the incidence of SIDS around the world (Jensen et al., 2012). To avoid confusion around proper 
terminology, the term SUDI has been used increasingly as an all-encompassing term describing all 
cases that involve the sudden and unexpected death of an infant under the age of one year (Weber et 
al., 2008), while SIDS has been used as a sub-classification of SUDI (Alfelali & Khandaker, 2014). 
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It is important to note that a diagnosis of SIDS can only be made after completion of a full medico-
legal investigation that involves various inter-disciplinary components (du Toit-Prinsloo et al., 2013; 
Hunt et al., 2015). 
2.4 SIDS: The Global Picture 
The incidence of SIDS was remarkably high in the second half of the 20th century, specifically 
between 1979 and 1989, even in developed countries (Toro et al., 2015). The problem has been an 
ever-present concern and has ultimately become a field of research in a vast number of scientific 
disciplines, inclusive of virology, microbiology, neuropathology, histology and genetics, among 
others (Blood-Siegfried, 2009). SIDS studies have mainly stemmed from the economically stable 
communities in Germany, New Zealand, USA and Britain and less so in developing communities in 
sub-Saharan Africa in an effort to better understand the underlying pathogenesis to this challenge. In 
2005, the incidence of SIDS in England and Wales was 0.41 deaths per 1 000 live births (Weber, et 
al., 2008), while an almost similar rate of 0.4 per 1 000 live births was seen in the same year in 
Germany (Vennemann et al., 2009). In 2009, SIDS incidence in the USA was 0.57 per 1 000 live 
births with over 2 000 infant deaths recorded every year (Adams et al., 2009). Six years later in 2015, 
close to 4 000 infants died suddenly and unexpectedly in USA, while 1 600 of those deaths were 
attributed to SIDS (Goldstein et al., 2016).  
The face down or prone sleeping position in infants is a modifiable risk factor for SIDS and as such 
was a target for intervention campaigns to address the increasing incidence of SIDS (Adams et al., 
2015). Through the initiation of the “Back to Sleep” campaign in the early 1990s, parents and 
caregivers were educated on the dangers of putting infants to sleep in the prone position. The 
campaign was a great success and saw a decrease of more than 50% in the incidence of SIDS (Adams 
et al., 2015; Mitchell & Krous, 2015; Ferrante et al., 2016). Despite this, SIDS is still regarded one 
of the leading COD in infancy in both developed and developing countries (Blackwell et al., 2015).  
Although the “Back to Sleep” campaign managed to reduce SIDS incidence by over 50% in the late 
1990s, SIDS still ranks among the leading post-neonatal COD in the first year of life. Other risk 
factors for SIDS pointing towards an infectious aetiology still exist. These include a peak winter 
incidence, exposure to cigarette smoke, poor socio-economic background and predominance of 
infants aged between two to four months (Raza & Blackwell, 1999; Fleming et al., 2015). The 
consensus in the scientific community is that SIDS is a problem that needs careful consideration and 
decisive action in both developed and developing communities (Blackwell et al., 2015). 
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With the various advancements in the scientific landscape over the past century, sudden and 
unexpected infant deaths have been a subject of more evidence-based scrutiny. This has enabled 
conduction of various research projects that have served as stepping stones for better understanding 
the dynamics of child and infant mortality, leading to various causes of infant death being reported.  
Substantial financial investments made over the years focussed on the role of respiratory viruses in 
SIDS as identified by different assays. Viral culture, immunofluorescence and PCR assays have 
detected HAdV, HRV, influenza, RSV and other viruses during SUDI case investigations (Weber et 
al., 2010), but none of them has been identified as the sole causative agent in sudden infant death. 
Respiratory viral infections are often acute and self-limiting and might therefore be less likely to 
directly lead to the death of an infant (Ghani et al., 2012).  
2.5 The South African Picture 
There is not nearly enough studies in South Africa on SUDI case investigations (du Toit-Prinsloo et 
al., 2013). As such, it is very difficult to predict the current incidence of SIDS in South Africa 
accurately. In Cape Town, South Africa, the estimated incidence of SIDS ranks among the highest in 
the world, being 3.41 per 1 000 live births (Dempers et al., 2016). Although there are seven academic 
medico-legal centres across South Africa, only two of these (Tygerberg and Pretoria) have been 
relatively active in SIDS research. Furthermore, there is no inter-institutional standardisation in the 
conduction of SUDI case investigations between these medico-legal institutions and this is as a major 
drawback to the establishment of a comprehensive source of SIDS incidence data (du Toit-Prinsloo 
et al., 2011).  
2.6 Risk factors for SIDS 
One of the most important questions that needed to be answered was whether all infants were equally 
vulnerable to succumbing to sudden death and if not, why not? Epidemiological studies and death 
scene investigations all over the world have identified various risk factors for sudden and unexpected 
death in infants. These risk factors are loosely categorised into namely socio-demographic, 
environmental, pregnancy, genetic and infection-related risks (du Toit-Prinsloo et al., 2011). 
2.6.1 Socio-demographic risks 
The socio-demographic characteristics of an individual are generally described by their age, sex, 
education and income. Infants aged between two and four months are at a greater risk of succumbing 
to SIDS. It is at this age that passively acquired maternal immunity wanes and the infant’s own 
immune system, although not fully mature yet, needs to combat any foreign pathogens (Moscovis et 
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al., 2014). As such, infants are most vulnerable during this time and a peak SIDS incidence at this 
age is not a coincidence.  
In addition, male infants are more likely to die suddenly and unexpectedly as compared to their female 
counterparts. An in vitro study to assess the cytokine responses of male and female peripheral blood 
mononuclear cells (PBMC) to a bacterial antigen challenge showed a lower production of pro-
inflammatory cytokines by males than females. This inability to produce sufficient cytokines against 
a bacterial antigen suggests possible vulnerability to infection (Moscovis et al., 2014).  
2.6.2 Sleep related risks 
The sleeping environment of infants is critical. The most significant sleep related SIDS risk identified 
over the years has been the sleeping position of the infant. An infant sleeping in a prone position was 
found to be at a greater risk for SIDS compared to infants who were put to sleep on their backs (supine 
sleeping position) (Vennemann et al., 2007). Additionally, prone sleeping may render infants more 
susceptible to infection of the URTI by pathogenic bacteria, especially if the infant sleeps on 
contaminated surfaces (Highet, 2008).  
The prone sleeping position was identified as an easily modifiable risk factor for SIDS and was 
therefore targeted for intervention. As mentioned previously, the American Academy of Pediatrics 
(AAP) and National Institutes of Health (NIH) came together in 1994 to implement the “Back to 
Sleep” campaign aimed at educating mothers and caregivers on the dangers of prone sleeping (Adams 
et al., 2009). Despite a 50% reduction in SIDS incidence rates achieved by campaigns such as this 
(Mitchell & Krous, 2015), SIDS is still regarded as a leading COD in infants under one year in 
developed countries (Blackwell et al., 2005).  
Co-sharing of a bed between an infant and a parent(s) or another individual(s) was also confirmed as 
a risk factor for sudden and unexpected death. The risk was significantly amplified in cases of low 
birthweight infants (Adams et al., 2009), direct exposure to cigarette smoke from parents or 
caregivers and the use of alcohol and drugs by parents or caregivers, both before and after birth (Gunn 
et al., 2000; Mitchell & Krous 2015). 
2.6.3 Pregnancy-related risks 
Infants born to young mothers were seen to be at an increased risk of dying suddenly and 
unexpectedly (Fleming et al., 2003), while smoking during the pregnancy exacerbated the risk. 
Evidence that premature birth increases the possibility of succumbing to SIDS also exists. Infants 
depend on passively acquired maternal antibodies for protection against infections. However, only a 
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limited number of antibodies are passed on to the infant during the first and second trimester of 
pregnancy. It is only after 32 weeks gestation that the infant starts acquiring maternal IgG (Crowe & 
Williams, 2003). As such, preterm infants are considered to be at a greater risk of developing more 
severe symptoms of RSV infection with possible subsequent SIDS compared to term infants (Horn 
& Smout, 2003; Mitchell & Krous, 2015). 
2.6.4 Genetic risks 
Over the years, research to try to elucidate the possible links between genetic factors and sudden 
infant death has delivered inconclusive findings. In 2004, Opdal and Rognum postulated the existence 
of a SIDS gene or genes and proposed two possible mechanisms in which genetic factors could play 
a role in sudden and unexpected death. The first was that specific gene mutations could give rise to 
metabolic disorders that can directly result in the death of an infant. Alternatively, a change in the 
morphology of a gene could predispose infants who found themselves in a vulnerable position to 
sudden infant death (Opdal & Rognum, 2004). However, the involvement of genes in the 
pathogenesis of SIDS is still inconclusive and mostly a matter of differing opinion.  
2.6.5 Infection related risks 
Evidence of infection has been well documented in SIDS cases over the years and other risk factors, 
such as the peak age range and high winter incidence, agree with increased vulnerability to URTI and 
LRTI (Raza & Blackwell, 1999). As early as the 1960s, SIDS investigations demonstrated viral 
presence in autopsies of 12 of the 48 infants included in the study (Alfelali & Khandaker, 2014). The 
peak incidence during winter months further supports the possible involvement of viral infections in 
the pathogenesis of SIDS (Morris, 1999; Alfelali & Khandaker, 2014), although viral infections are 
common in young, living children as well (Samuels, 2003). These infections are rarely severe and 
cause acute URTI and LRTI that often resolve without any major complications (Ghani et al., 2012). 
As such, it is possible that the existence of some other factors rather than infection alone, predispose 
an infant to sudden and unexpected death. Infants may have an inherited condition or conditions 
rendering them susceptible to viral infections and more at risk of SIDS than the mere presence of the 
virus itself. Environments that expose infants to tobacco smoke also enhance the susceptibility of an 
infant to a viral infection that otherwise would not have been fatal in the first place (Samuels, 2003). 
The inflammatory response to infection has been identified as an important potential role player in 
the sequence of events that lead to infant death (Blackwell et al., 2002).  
Although bacteria, such as Staph aureus, Haemophilus influenzae, Strep pyogenes and Strep 
pneumoniae have been identified in culture during SUDI medico-legal investigations, none have been 
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consistently associated with sudden and unexpected infant death (Forsyth, 1999), with some being 
dismissed as PM contamination (Rambaud et al., 1999). 
2.7 Mechanisms of death 
The Triple Risk Hypothesis was first proposed by Rognum and Saugstad (1993) and subsequently 
described by Filiano and Kinney (1994). It emphasises the multifactorial nature of SIDS (Figure 2.4), 
where risk factors are not the sole cause of sudden infant death, but merely increase the infant’s 
susceptibility which may lead to death (Blood-Siegfried, 2009). 
 
Figure 2.4 The Triple Risk Hypothesis (adapted from Filliano & Kinney, 1994) 
The sequence of events that ultimately lead to the death of a seemingly healthy infant is still not fully 
understood. Accidental suffocation, metabolic disease and sudden hypoxaemia are some of the 
physiological mechanisms that can contribute to infant death. Hypoxaemia can be a result of 
respiratory infections in some instances (Samuels, 2003). Although several hypotheses about SIDS 
have been proposed, it is generally agreed that the sudden death of an infant results when various 
circumstances or events trigger a reaction at a specific, opportune time of vulnerability. Therefore, 
the Triple Risk Hypothesis suggests that sudden death in infants is most likely to occur when there is 
an overlap of external stressors (viral infection or bed-sharing) in a vulnerable infant (one with a 
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prenatal brainstem injury or other predisposing genetic factor) at a critical developmental stage in the 
life of the infant (two to four months of age) (Guntheroth & Spiers, 2002). 
2.8 Respiratory viruses in infancy and SIDS 
Viral respiratory infections play a role as potential triggers in SIDS (Samuels, 2003). Infancy is a 
very early stage of growth and development and as such represents the most vulnerable period of life. 
At this stage in life, an infant depends on short-lived maternal immunity passed on from their mothers 
during the pre- and post-natal period for protection against invading pathogens. The infant’s immune 
system at this point is not yet fully developed and capable to combat the various immune challenges 
that may be presented to it on its own. It is also at this time when infections with various bacteria and 
viruses are most likely to happen (Goenka & Kollmann, 2015). Viral LRTI can lead to an influx of 
inflammatory cells into the lungs, causing damage to the lung tissue as seen with RSV infections. As 
such, the infiltration of these cells into the tissue has to be well regulated to prevent damage to the 
lungs themselves while fighting off the pathogen (Loebbermann, et al., 2012). 
Viral infections are often implicated in infant morbidity and mortality (Ghani et al., 2012). 
Additionally, acute respiratory infections are some of the leading causes of morbidity and mortality 
in infants and young children (Williams et al., 2002). During winter, children worldwide are most 
frequently hospitalised because of viral respiratory infections (Melendi et al., 2007).  
Dagan et al. (1989) conducted a study in the USA on previously healthy infants less than three months 
of age to determine the frequency of viral infections in infants brought to the hospital with a suspicion 
of bacterial infection and found that these two types of infection (bacterial and viral) occurred in 
tandem in their study participants. The most isolated viruses in this study were RSV, influenza A and 
HEV, while RSV and influenza A were not detected in their control group. Viruses commonly 
associated with acute LRTI in infants include HPIV, influenza, RSV and HAdV (Choi et al., 2006). 
Viral respiratory infections in the first year of life occur frequently and more than 50% of infants 
have a LRTI during this period (Ghani et al., 2012). Although it causes severe upper and lower 
respiratory symptoms in some cases, the symptoms in a majority of cases are not life threatening and 
while some infants are hospitalised; only a few need paediatric intensive care (Samuels, 2003; Ghani 
et al., 2012). In addition to the seemingly innocuous nature of the respiratory virus infections, pre-
existing comorbidities like prematurity, malnutrition and cardiac abnormalities may predispose an 
infant to a more severe viral infection (Ghani et al., 2012). This supports the hypothesis that more 
than a single infection is necessary to predisposes an infant to sudden and unexpected death. Infants 
that have inherited conditions or are in environments that expose them to tobacco smoke are more 
susceptible to viral infections that would otherwise not have been fatal. As stated before, the 
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inflammatory processes that take place in response to infections have been confirmed as potential 
role players in the sequence of events that lead to infant death (Blackwell et al., 2002).  
Although quite a number of viruses have been associated with sudden death of infants, none of them 
has been independently implicated in this regard. Some of the viruses detected during SUDI case 
investigations are shown in Table 2.1. Quite a few bacterial species and their toxins have also 
consistently been isolated from PM SUDI samples. These include Staph aureus, Escherichia coli, 
Clostridium perfringens and Clostridium botulinum, amongst others. These bacterial pathogens 
induce their effect through the release of endotoxins that have various effects on the body’s 
physiology (Blackwell et al., 2002; Highet, 2008).  
Table 2.1 Viruses identified in SUDI investigations 
Identified Viruses References 
Adenovirus Williams et al., 1984; Weber et al., 2010 
Cytomegalovirus Fernandez-Rodriguez et al., 2006; Desmons et al., 2013 
Enterovirus Weber et al., 2010 
Influenza A and B Williams et al., 1984; Weber et al., 2010 
Parainfluenza Williams et al., 1984 
RSV Williams et al., 1984; Weber et al., 2010 
Varicella zoster virus Desmons et al., 2013 
 
2.8.1 HAdV 
HAdV is a double-stranded, deoxyribonucleic acid (DNA) virus, belonging to the family 
Adenoviridae (Mahony, 2008). Ever since it was first isolated in 1953, more than 60 HAdV types 
have been described. Of these, respiratory tract infections are caused by HAdV subtypes B, C and E 
(Liu et al., 2015). 
2.8.2 HBoV 
HBoV was first discovered in 2005 in NPAs at Karolinska University in Sweden (Allander, 2008). 
The NPAs had been obtained from patients suspected of having a respiratory tract infection. It is a 
single-stranded DNA virus within the family Parvoviridae, subfamily Parvovirinae, and genus 
Bocavirus (Mahony, 2008).  
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2.8.3 Human Influenza virus 
This is a negative-sense single-stranded ribonucleic acid (RNA) virus, belonging to the 
Orthomyxoviridae family. Influenza virus is responsible for annual epidemics in temperate regions 
and causes illness consistent with an URTI (Mahony, 2008). 
2.8.4 HMPV 
Discovered in 2001 in Netherlands, HMPV is a negative-sense, single-stranded RNA virus that 
belongs to the Paramyxoviridae family, subfamily Pneumovirinae and genus Pneumovirus (Mahony, 
2008). It causes pneumonia, URTIs and bronchiolitis of lower severity than RSV (Guerrero-Plata et 
al., 2005). 
2.8.5 HPIV 
The HPIV is a single-stranded, negative-sense RNA virus belonging to the Paramyxoviridae family. 
Four serotypes in this family (PIV 1-4) are infectious to humans but PIV 3 is the major problem in 
infants especially in the cold months as it causes severe LRTI leading to bronchitis and pneumonia 
(Mahony, 2008). 
2.8.6 RSV 
RSV is a single-stranded, enveloped RNA virus first isolated in 1956 from a chimpanzee suffering 
from respiratory problems. It belongs to the genus Parapneumovirus within the subfamily 
Pneumovirinae and the family Paramyxoviridae. This is the same family that HMPV belongs to 
(Mahony, 2008). Two antigenic subtypes of RSV exist, namely RSV A and RSV B; the former 
causing more severe disease ranging from mild symptoms to severe and potentially life threatening, 
while RSV B infection is mostly asymptomatic. RSV is a leading cause of LRTI in infants, causing 
pneumonia and bronchiolitis. In the USA, 60% of infants are infected with RSV by age one, with the 
figure rising to 90% by the age of two. Prematurity, congenital heart disease and a deficient T-cell 
response predispose infants to more severe forms of RSV infection (Welliver, 2003).  
2.8.7 HRV 
These are positive-sense, single-stranded RNA viruses from the Picornaviridae family (Mahony, 
2008). Like anywhere in the world, HRV infections are common throughout the year in South Africa, 
peaking in autumn and spring (Smuts et al., 2011). Respiratory tract infections usually involve HRVs 
and they are an important cause of the common cold. They cause both URTI and LRTI in infants, 
manifesting as bronchiolitis and exacerbation of asthma often resulting in hospitalisation (Busse et 
al., 2010; Piper et al., 2013).  
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A virus can potentially contribute to SUDI in various ways. According to Vege and Rognum (1999), 
an improper or uncontrolled immune reaction to a respiratory viral infection exacerbates a seemingly 
harmless viral infection into a fatal one (Vege & Rognum, 1999). However, Forsyth is of the opinion 
that an uncontrolled immune reaction to viral and bacterial infections triggers a sequence of events 
that ultimately lead to the eventual death of an infant (Forsyth, 1999; Weber et al., 2010).  
2.9 The immune system and response to viral infections 
As the maternally derived IgG antibodies begin to wane off, the infant’s immune system takes over 
the burden of full time defence against pathogens. It starts producing cell signalling and regulatory 
molecules, such as cytokines, chemokines and other immune biomarkers in response to invading 
organisms. In this way, a specific, co-ordinated and controlled inflammatory response is produced to 
contain and clear the pathogens. Immune system molecules produced in response to viruses include 
interleukin (IL)-1α, IL-1β, IL-6, interferon (IFN)-γ and tumour necrosis factor (TNF)-α. CRP, an 
acute phase protein, is another molecule produced by the liver and released into circulation soon after 
infection occurs. Levels start increasing within 6 hours and reaches a peak around 48 hours (Fujita et 
al., 2002), but the absence of elevated CRP does not exclude the possibility of an infection or 
inflammation prior to death.  
When a competent immune system encounters foreign particles, such as bacteria and viruses, it reacts 
to minimise the potential damage that the microorganism might cause and eventually rid the body of 
the invading pathogen. The first line of defence against viruses is the skin and other components of 
the innate immune response. The innate immune system makes use of pattern recognition receptors 
(PRRs), such as Toll-like receptors (TLRs) and NOD-like receptors (NLRs) to confirm the presence 
of the virus. These receptors identify pathogen associated molecular patterns (PAMPs) and danger 
associated molecular patterns (DAMPs), which are associated with viruses and other pathogens. This 
initial recognition leads to the activation and recruitment of immune cells via the upregulation of cell 
adhesion molecules and secretion of various specific and non-specific immune molecules, such as 
cytokines, chemokines and other acute phase proteins into the bloodstream to induce an inflammatory 
reaction (Pryce et al., 2014; Donovan et al., 2016). Over the years, viruses have devised mechanisms 
to evade the immune system. Once the virus evades the innate immune response, cells of the adaptive 
immune system respond to limit the damage caused by the virus by continuing the release of immune 
biomarkers, like cytokines, chemokines and other mediators of inflammation. This leads to 
neutralisation of the effects of viral entry and replication in cells and eventual virus removal from the 
body. Although the ultimate aim of the immune system is to clear the virus from the body, it does so 
in differing ways. Different immune responses are elicited by different viruses and this was shown in 
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in RSV-infected infants, where there was a marked increase in serum IL-4 and IL-5 (T-helper 2 cell 
cytokines), while in influenza A-infected infants responded with a predominance of TNF-α, which is 
a T-helper 1 cell cytokine (Sung et al., 2001). Once the inflammatory response is complete, the 
immune biomarkers persist in circulation for a while, depending on their half-life. This property 
makes them an ideal target for identifying a prior inflammatory event.  
2.10 Inflammation and SIDS 
Viral respiratory symptoms are observed two weeks prior to sudden and unexpected death in 44% of 
SIDS cases and these symptoms have been linked to evidence of inflammatory processes (changes in 
respiratory epithelium) seen in SUDI case investigations (Goldwater, 2004). This may play a 
significant contributory role towards SUDI. Mistchenko et al. (1994) conducted a study on HAdV 
infections in infants and showed the involvement of various cytokines in the inflammatory processes 
elicited by severe HAdV infections. They also suggested that circulating immune complexes might 
have been deposited on tissue and ultimately led to the eventual tissue damage observed.  
Observation of significant inflammatory changes in tissue can be used as an indicator of a prior 
pathological event (infection) and in forensic pathology, tissue histology is regarded as the gold 
standard in determining the ultimate COD when performing autopsies (Uhlin-Hansen, 2001; 
Blackwell et al., 2015). However, histology results alone at times may not be sufficient to determine 
the COD. As such, some studies in Europe and the USA included biomarkers of inflammation by 
measuring serum cytokines as an indicator of infection or an inflammatory process prior to the death 
of an infant (Vennemann et al., 2012). However, there is a paucity of this kind of information or such 
studies being conducted in South Africa. 
A history of a mild viral infection and immune stimulation of the URTI prior to death is often reported 
in SIDS cases (Raza & Blackwell, 1999; Vege & Rognum, 1999; Blackwell et al., 2015). Studies on 
the possible roles played by cytokines and chemokines in sudden infant death have produced various 
results. While some studies failed to identify a significant difference in levels of serum and CSF 
cytokines (IL-1β, IL-6 and TNF-α) observed in SIDS compared to non-SIDS cases (Vennemann et 
al., 2012), some have shown increased CSF IL-6 levels in SIDS cases compared to non-SIDS cases 
(Vege et al., 1995). Some researchers have hypothesised that an inflammatory response to an 
infection precipitates a sequence of events that culminate in the death of the infant. Blackwell et al. 
(2015) showed just how detrimental to survival an incompetent inflammatory response is to the 
infant’s chances of survival. It is possible that sudden infant death is partly a result of failure of the 
infant’s immune system to regulate the innate inflammatory process against a viral infection (Forsyth, 
1999).  
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2.11 Cytokines in SUDI 
Cytokines are a group of peptide, signalling molecules secreted by various cells of the immune system 
in response to a foreign object or invading pathogen in the body. They are involved in the mediation 
and regulation of the inflammatory response to ensure that it is controlled and coordinated. Cytokines 
can be classified as pro-inflammatory or anti-inflammatory based on their effect. Various cytokines 
have been studied in SUDI case investigations to analyse the role that these molecules play in the 
inflammatory processes that take place in sudden infant death cases. 
Pro-inflammatory cytokines, such as IL-1α, IL-β, IL-6, IL-12, IFN-γ and TNF-α, induce an immune 
response that targets control and eventual clearance of an invading pathogen. However, when the 
immune response is left uncontrolled, it can spiral out of control and cause more damage to the host 
than what the invading pathogen itself might have done (Opal & DePalo, 2000). Anti-inflammatory 
cytokines, such as IL-4, IL-6, IL-10, IL-11, IL-13, transforming growth factor (TGF)-β) and IL-1 
receptor antagonist (IL-1RA), are important to dampen the action of pro-inflammatory cytokines, 
thus regulating the duration of the inflammatory process and preventing host cell damage by the 
immune system.  
Various viruses can infect the respiratory tract of infants, but none of them induces pathognomic 
symptoms. Infection by two different respiratory viruses can produce a similar clinical picture. The 
cytokines that are released by the immune system in response to a virus differ according to the nature 
of the virus. This is particularly important in cases of RSV and HMPV infections that produce 
clinically similar manifestations. In a study by Guerrero-Plata and colleagues (2005) investigating 
the immune response tot RSV and HMPV in BALB/c mice, different cytokine profiles were observed 
for the different infections. After 24 hours, the levels of IL-1α, IL-1β, IL-6, TNF-α in bronchoalveolar 
lavages (BAL) collected from mice infected with either virus were found to be significantly higher in 
RSV-infected mice than in HMPV-infected mice. IFN-α, a major component of the innate immune 
response to viruses, was significantly increased in HMPV-infected mice compared to RSV-infected 
mice (Guerrero-Plata et al., 2005). In addition, BAL IFN-γ (a key component of antiviral activity) 
levels were increased in RSV-infected mice compared to HMPV-infected mice one day post-
infection, but only slightly increased five days post infection. RSV infection was also able to induce 
production of IL-10, IL-12p70 and IL-10 whereas HMPV infection failed to induce the production of 
these cytokines.  
Cytokines have various effects on different systems in the body depending on the physiological needs 
and some of their major roles in infection and inflammation are outlined below. 
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2.11.1 CRP 
It is an acute phase protein produced in the liver and is responsible for non-specific activation of the 
immune system upon detection of an invading pathogen. Circulating serum CRP levels can increase 
as a result of an inflammatory stimuli and remain elevated for up to six days after death (Uhlin-
Hansen, 2001). 
2.11.2 TNF-α 
CD8+ effector T cells are responsible for the eradication of cytopathic viruses through the secretion 
of TNF-α and IFN-γ (van den Broek, et al., 2000). 
2.11.3 IFN-γ 
IFN-γ is a type II interferon mainly produced by natural killer (NK) cells, a large proportion of which 
are found in the lungs. However, CD4 T-helper cells and CD8 T-cytotoxic cells can also produce 
IFN-γ after the development of antigen-specific immunity. Some of its major roles in the immune 
system include enhancing phagocytosis and directly limiting the replication of an invading virus 
(Newton et al., 2016). Abboud et al. (2015) confirmed in a mouse model the essential role of IFN-γ 
in limiting the replication of vaccinia virus and eventual clearance of the virus with the help of CD8 
T cells. 
2.11.4 IFN-γ induced protein 10 (IP-10) 
IP-10, also known as CXCL10, is a chemokine whose receptor, CXCR3, is found on activated T 
lymphocytes and NK cells. In the event of a viral infection, the chemotactic abilities exhibited by IP-
10 are responsible for the recruitment of activated T lymphocytes and NK cells to the site of infection. 
Studies suggest that IP-10 expression can be induced by a viral infection, such as chronic hepatitis C 
virus (HCV) infection. HCV, present in the hepatocytes, induces IP-10, which in turn leads to the 
migration of inflammatory cells into the liver lobules; a vital indicator of the progression of disease. 
IP-10 expression has been correlated with inflammatory activity (Harvey et al., 2003). In a study 
conducted to evaluate chemokine responses to serious acute respiratory illness in BAL samples, IP-
10 levels were significantly increased in patients where a virus had been detected by multiplex PCR 
in comparison to those where no virus was detected (Sumino et al., 2010).  
2.11.5 IL-1 
An agonist is a molecule which, when combined with a receptor, initiates a physiological response. 
The IL-1 family comprises of two such agonists, namely IL-1α and IL-1β and these are important in 
host defence against organisms that divide inside cells. In addition, there is also a receptor antagonist, 
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IL-1RA, which binds to the IL-1 cell surface receptors, thus inhibiting the activity of IL-1. In patients 
with an infection or inflammatory condition, IL-RA levels are increased. If there is an imbalance in 
the levels of IL-1 and IL-RA, inflammatory disease and structural damage can be observed in the 
lungs and other organs (Arend, 2002). IL-RA has strict anti-inflammatory properties. It is produced 
by macrophages to inhibit the activation of cells by IL-1α and IL-1β by competitive blocking of 
membrane bound IL-1α and IL-1β receptors. IL-RA release is elicited by the presence of bacterial 
lipopolysaccharide (LPS) in the circulation (Opal & DePalo, 2000). 
2.11.6 IL-6 
IL-6 is produced by B and T cells, as well as monocytes. Although it is often identified as both a pro- 
and anti-inflammatory cytokine, IL-6 is mostly involved in anti-inflammatory responses. Its main 
function is to inhibit the production of the pro-inflammatory cytokines IFN-γ, Macrophage 
Inflammatory Protein (MIP)-2), IL-1 and TNF by macrophages, while favouring the production of 
IL-RA. 
2.11.7 IL-8 
Also known as CXCL8, this chemokine is produced by macrophages as an innate immune response 
to infection and is mainly involved in inducing the migration of neutrophils to the site of infection. 
2.11.8 IL-10 
It is regarded as the most important anti-inflammatory cytokine in the human immune response due 
to its potency. It is mainly produced by the T helper-2 cells, monocytes and B cells. It is involved in 
downregulating the expression of pro-inflammatory cytokines, such as IFN-γ, IL-1β and TNF-α. 
2.11.9 IL-12 
IL-12 is an important cytokine responsible for inducing the development of CD4+ T helper cells that 
are essential for viral clearance (van den Broek, et al., 2000). 
As stated before, detection of viral nucleic acid alone with multiplex PCR is not enough to classify 
the COD as infection in SUDI cases. As such, understanding the interactions of the immune system 
with an invading virus and the resulting inflammatory changes as observed in tissue samples may 
prove to be vital in shedding more light into the possible role of viral infections in the events leading 
up to SUDI. 
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CHAPTER 3: MATERIALS AND METHODS 
3.1 Ethics 
The Stellenbosch University Health Research Ethics Committee (HREC) first approved this project 
on the 7th of March 2012 (Ethics Reference Number N12/02/007). The ethics approval was renewed 
on an annual basis. Since the investigations conducted in this study did not deviate from the routine 
laboratory investigation protocol for respiratory pathogens in SUDI cases, a waiver of consent was 
granted, meaning that the deceased infants’ parents did not have to give additional permission for the 
collection of samples to be used in the study. 
3.2 Study design 
The study was a cross-sectional, analytical, descriptive study, divided into two parts. The first part of 
the study was virological testing of swabs collected from the left and right lung well as the trachea of 
all SUDI cases admitted to the Tygerberg Medico-Legal Mortuary between July 2015 and June 2016. 
The second part of the study was testing for 16 immune biomarkers in serum samples collected from 
all SUDI cases admitted to the Tygerberg Medico-Legal Mortuary between July 2015 and June 2016.  
3.2.1 Inclusion criteria 
Death must have been sudden and/or unexpected and the circumstances must have been unexplained. 
The case must have presented as SUDI in terms of the definitions of the National Health Act, (No 61 
of 2003) and the subsequently formulated Forensic Pathology Guidelines on unnatural deaths. The 
age of the infant should also have been between one day and one year at the time of death. 
3.2.2 Exclusion criteria 
Infants who died of unnatural causes and/or were above the age of one year at the time of death were 
excluded from the study. 
3.2.3 Data collection method 
Socio-demographic information from SUDI cases was collected from parents or caregivers by the 
Forensic Pathology Officers at the scene of death and at the medico-legal mortuary by completing a 
standard questionnaire. From these questionnaires, socio-demographic information relevant to the 
study (age, sex, PMI, season, sleeping position, medical history prior to death) was then collected and 
entered into a dedicated database. The questionnaire is attached as Addendum A1. 
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3.3 Aims and Objectives 
The main aims of the study were: 
• To profile respiratory viruses observed in lungs and trachea in SUDI case investigations conducted 
at the Tygerberg Medico-Legal Mortuary. This objective was carried out by conducting multiplex 
PCR on nucleic acid extracts from lung and tracheal swabs using the Seeplex RV15 ACE detection 
kit.  
• To measure the levels of immune biomarkers (cytokines, chemokines and an acute phase protein) 
in serum from all SUDI cases admitted to the Tygerberg Medico-Legal Mortuary between July 
2015 and June 2016 and assessing their usefulness as indicators of infection or inflammation prior 
to or at the time of death of the infant. 
Different specific objectives were defined and various methods utilised to achieve them as shown 
below: 
3.4 OBJECTIVE 1  
a) To prospectively collect the lower lobes of the left and right lungs from SUDI cases for histological 
examination by forensic pathologists at the Forensic Pathology Division; 
b) To prospectively collect heart, left and right lung swabs for routine culture testing by the NHLS 
Microbiology laboratory; 
c) To prospectively collect blood, as well as lung and liver tissue for routine testing by the NHLS 
Virology laboratory.  
3.4.1 Sample collection 
As part of the standard, institutional investigation protocol for SUDI cases at the Tygerberg Medico-
Legal Mortuary, samples were collected for routine virology, microbiology and histological 
examination.  
3.4.2 Routine histology samples 
The lower lobes of both the left and right lung tissue were collected for the purposes of histological 
examination by forensic pathologists. Prior to sample collection, the forensic pathologist conducting 
the PM inspected the lungs for any macroscopic abnormalities, such as petechial haemorrhages. 
Afterwards, sterile blades and scalpel handles were used to excise the entire lower lobes of both lungs. 
The tissue samples were then placed in pre-labelled, 90 ml polypropylene tubes (CJ Labs, Cape 
Town) and transported within 10 minutes to the Forensic Pathology Division where 10% formalin 
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was added. The time interval between tissue sample collection and addition of formalin was not 
prolonged and as such prevented autolysis of tissue.  
Histological preparation of tissue 
To prepare slides for histological examination, 5 mm x 5 mm pieces of tissue from the deeper part of 
both lungs were cut separately using a sterile blade and placed into two different plastic cassettes 
labelled with the unique case number (WC/14/case_number/year). The tissue was secured in the 
cassette using a cassette cover and immediately placed into 10% formalin for 24 hours to facilitate 
tissue fixation. Afterwards, the cassette was placed in a Tissue-Tek VIP 5 Jr tissue processor where 
the tissue was processed as follows: 
• Fixation – tissue was placed in 10% formalin (1 hour). 
• Dehydration – after fixation, the tissue was immersed in increasing alcohol concentrations (70%, 
85%, 96% and 100% alcohol) (3 hours). 
• Clearing – the alcohol was then removed from tissue by placing tissue in pure xylene (3 hours). 
• Impregnation – tissue was placed in paraffin wax to fill any gaps in the tissue (4 hours). 
After completion of tissue processing, tissue blocks were embedded in paraffin wax; ensuring the 
correct orientation of the tissue to facilitate the cutting of tissue sections that include the histology 
being investigated. The tissue blocks were placed on an ice tray to rapidly cool down and solidify, 
thereby facilitating cutting of sections as soon as possible after processing. A MICROM microtome 
was used to cut sections of 3 µm thick. The sections were floated in a 60°C water bath to allow 
melting of the wax. Afterwards, the sections were picked up and placed onto an appropriately labelled 
glass slide. The slide was dried by placing it in a Scientific Series 9000 incubator at 77°C for 30 
minutes, immediately placed into xylene to remove any remaining wax and the following steps were 
followed prior to staining: 
• Hydration – to remove xylene from the sections by briefly placing the slides in decreasing 
concentrations of alcohol (100%, 96%, 85% and 70%). 
• The sections were then rinsed in tap water and placed in haematoxylin for five minutes to stain the 
nucleus; followed by rinsing in tap water and placing in Scotts tap water to intensify the colour of 
the haematoxylin. 
• Tap water was again used to rinse the sections and the sections immediately placed in eosin to 
stain the cytoplasm, after which they were rinsed in tap water. 
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• Dehydration – water was then removed by placing the slide in increasing concentrations of alcohol 
(70%, 85%, 96% and 100%). 
• Clearing – alcohol was then removed by placing the slide in pure xylene and a cover slip placed 
on top of the section and DPX used as a mounting medium. The slide was air dried before being 
assessed under a light microscope by forensic pathologists. 
3.4.3 Routine microbiology samples 
Swabs from the left and right lungs, as well as heart, were collected for microbiological tests. For the 
lung swabs, a clean pair of forceps was used to lift the lower lobe of either lung, after which the lateral 
surface of the lung was sterilised by scorching. A sterile blade was used to make an incision on the 
scorched surface of the lung. A swab was inserted into the incision and rotated a few times to ensure 
maximum sample collection.  
The lateral surface of the left ventricle of the heart was then sterilised by scorching, after which a 
sterile blade was used to make an incision into the left ventricle without disturbing the anatomy too 
much. A swab was inserted into the incision and rotated a few times. Soon after sample collection, 
the swabs were placed back into the original tubes and transported to the Microbiology Division for 
processing.  
Swab processing 
The swab samples were processed at the Microbiology Division of the NHLS laboratory at Tygerberg 
Hospital. After confirmation at the pre-analytical desk that the information on request forms and 
samples matched, the three swab samples were taken to the analytical desk for processing as follows: 
• Three different agar plates (Chocolate, Blood and MacConkey) were appropriately labelled with 
the case number and sample type as it appeared on the request forms (Figure 3.1). 
• Each swab sample was inoculated into each of the three different agar plates and a three-way streak 
conducted.  
• The nine plates were incubated in a jacketed NUAIRE CO2 incubator at 36°C and 5.5% CO2 for 
18-24 hours to allow for microbial growth. 
If there was no growth evident after 18-24 hours, the plates were incubated for another 18-24 hours 
under the same conditions. However, if there was general growth of organisms, biochemical 
confirmatory tests like the Gram stain, BBL Sensi-Disc susceptibility test and Analytical Profile 
Index (API) were conducted. If biochemical tests could not identify the organism growing on a plate, 
a Biomerieux VITEK 2 XL machine was used to identify the organism. 
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Figure 3.1  The three agar plates, Chocolate (A), Blood (B) and MacConkey (C), used for the culture 
of microorganisms  
3.4.4 Routine virology samples 
Three sample types were collected for routine testing at the NHLS Virology Division laboratory as 
part of SUDI case investigations at the Tygerberg Medico-Legal Mortuary. These include whole 
blood, as well as left lung and liver tissue.  
Lung and liver tissue collection 
Small pieces of the liver and left lung tissue were collected for routine centrifugation-enhanced SVC 
according to the institutional protocol. A sterile blade and scalpel handle was used to cut a 5 mm x 
5 mm piece of left lung tissue, which was placed into red top glass tube. A new, sterile blade was also 
used to cut a 5 mm x 5 mm piece of liver tissue, which was also placed in an appropriately labelled 
red top glass tube. The samples were transported to the laboratories in 1.5 ml of Universal Transport 
Medium (UTM), aliquoted into each of the two glass tubes to preserve any viruses present.  
Heart blood collection 
The pericardial sac was cut open to expose the heart for macroscopic examination by a forensic 
pathologist prior to whole blood collection. The heart apex was then lifted using sterile forceps to 
allow blood to be drawn from the base of the heart using a 5 ml syringe and sterile 15-gauge needle. 
The collected blood was transferred to a red top glass tube. The tissue and blood specimens were 
transported to the Virology Division for processing. 
Stellenbosch University  https://scholar.sun.ac.za
 30 
Routine SVC 
SVCs were routinely used to test for nine viruses4 in all SUDI cases at the Tygerberg Medico-Legal 
Mortuary. Lung tissue was screened for all nine viruses, while the liver was only screened for HAdV 
and CMV. Three different cell lines stored at 37°C in an ESCO CelCulture CO2 incubator were used 
for culture, depending on the target virus. Human Fibroblast (HF) cells were used to culture CMV, 
while a combination of Madin-Darby Canine Kidney (MDCK) and Hep 2 cells was used to culture 
HAdV, HMPV, Influenza A and B and HPIV 1-3. 
Sample Processing for culture 
After reception of samples at the Virology laboratory, lung and liver specimens were placed into 
separate mortars and ground with a pestle. Antibiotic cocktail (0.2 ml) was added to 6 ml viral 
transport medium (VTM) and the mixture was then added to the ground tissue and allowed to stand 
for five minutes. Thereafter, it was transferred to appropriately labelled 15 ml centrifuge tubes and 
centrifuged at 2 000 rpm for 10 minutes at 4°C. The specimens were then passed through a 0.2 µm 
disposable syringe filter attached to a 10 ml syringe (Figure 3.2) to trap any bacteria that might be 
present. 
 
Figure 3.2  Syringe and filter for filtering bacteria possibly present in the ground lung and liver 
tissue in preparation for culture in the shell vials 
                                                 
4 HAdV, CMV, Influenza A & B, HMPV, HPIV 1-3, RSV 
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Inoculation and incubation of prepared sample 
Two vials with coverslips inside were labelled with the appropriate sample number. Each vial 
contained cell lines, media and antibiotics according to the target viruses as shown below: 
• HF cells: Rosswell Park Memorial Institute (RPMI) 1640 medium, 10% foetal calf serum, 
penicillin and streptomycin. 
• MDCK and Hep 2 cell combination: Eagle’s Minimum Essential Medium (EMEM), 10% foetal 
calf serum, penicillin and streptomycin. 
The prepared tissue samples (200 µl) were inoculated into the appropriate shell vials according to the 
target viruses. The shell vials were then centrifuged at 3 000 rpm for 45 minutes in a Heraeus 
Megafuge 40 centrifuge to enhance viral entry into the cells. After centrifugation, 1 ml of EMEM 
was added to the vial with MDCK and Hep 2 cell combination and incubated at 33°C for 48 hours. 
In the other vial with HF cells, 1 ml of RPMI 1640 medium was added and incubated at 37°C for 48 
hours. 
After incubation, the coverslips were taken out of the shell vials and fixed in 2 ml cold acetone for 
10 minutes to prevent the cells from being washed off. 
Determination of culture results 
A Respiratory Panel Viral Screening and Identification Immunofluorescence Assay kit (Light 
Diagnostics, United States of America) was used to determine the culture results. Initially, the cover 
slips were mounted on a glass slide with Entellan. Afterwards, one drop of a cocktail of monoclonal 
antibodies against all target viruses was added to the appropriate coverslips and incubated at 37°C for 
30 minutes. The coverslips were washed with PBS and anti-mouse IgG:Fluorescein isothiocyanate 
(FITC) antibodies added and the coverslips incubated at 37°C for 30 minutes. Afterwards, the 
coverslips were washed with phosphate-buffered saline (PBS), air dried, mounted and read under a 
fluorescence microscope in a dark room.  
Confirmation of positive culture results 
Positive screening results after culturing of tissue using a cocktail of monoclonal antibodies were 
confirmed and the virus identified as follows: 
• The supernatant fluid from the SVC was transferred to labelled 2 ml tubes and the shell vials rinsed 
with PBS. 
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• 2 ml of PBS was poured into the shell vials and a plastic bulb used to scrape the cells off the 
coverslip. 
• The solution was pipetted into the labelled 2 ml tubes and centrifuged briefly for 30 seconds. 
• After centrifugation, supernatant fluid was discarded and 150 µl of PBS added to the cell pellet. 
• The cell pellet and PBS were then thoroughly mixed, after which 15 µl was pipetted into each of 
the nine wells on a multi-well Teflon slide and allowed to air dry for 30 minutes. 
• The slide was then fixed in cold acetone for 10 minutes.  
• After fixation, an immunofluorescence test was conducted by adding antisera specific to each 
target viruses to the wells on the Teflon slide to determine which specific virus was responsible 
for the initial positive immunofluorescent assay (IFA) screening result. 
IFA Interpretation  
Positive result – apple green fluorescence in nucleus and/or cytoplasm (Figures 3.3 and 3.4). 
Negative result – dull red staining of cells (Figure 3.5). 
 
Figure 3.3  CMV positive result on HF cells characterised by apple green fluorescence under a 
fluorescence microscope 
 
Figure 3.4 HAdV positive result on HF cells characterised by apple green fluorescence under a 
fluorescence microscope 
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Figure 3.5  CMV negative result on HF cells. Note the absence of apple green fluorescence 
3.4.5 Routine HIV 1/2 Antibody testing 
Detection of antibodies against HIV 1/2 proteins, such as glycoprotein (gp)36, gp41 and p24, 
indicates either exposure to HIV or the possibility of maternally acquired antibody in infants under 
the age of 18 months. As part of the routine SUDI investigation protocol at Tygerberg Medico-Legal 
Mortuary, HIV 1/2 antibodies were tested for in serum from SUDI cases using a rapid VISITECT 
HIV 1/2 Antibody kit (Omega Diagnostics, Randburg). The kit is a point-of-care, qualitative 
immunoassay for the detection of antibodies to HIV 1/2 by utilising immunochromatography. The 
test device comprises of a membrane containing recombinant HIV 1/2 antigens conjugated to 
colloidal gold on the test line R. Also on the membrane is goat anti-rabbit IgG conjugated to colloidal 
gold on the control line C. If the sample contains HIV 1/2 antibodies, the antibodies form a complex 
with the colloidal gold-recombinant HIV 1/2 antigens conjugate which moves further along the 
membrane until it is immobilised by specific recombinant HIV 1/2 antigens at the test region. A pink 
line indicates a positive HIV 1/2 antibody result in the sample. Any unreacted or unbound complexes 
and colloidal gold conjugated rabbit IgG move along the membrane where they are immobilised by 
goat anti-rabbit IgG on the control region C. This serves as a performance validation of the entire test 
procedure (Figure 3.6).  
A test result was only valid if there was a visible line in the control region marked C in Figure 3.6. In 
the absence of the line, the test was deemed invalid and repeated. 
Test procedure 
• Whole blood was centrifuged at 3 000 rpm for 10 minutes prior to testing. 
• The pouch containing the test device was taken out of the refrigerator where it was stored at 4°C.  
• The test device was labelled with the last four digits of a unique identifying number allocated to 
the sample at the Virology laboratory pre-analytical desk. 
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• Four drops of serum were added to the rectangular window marked S using a bulb pipette; followed 
by addition of five drops of diluent buffer to the circular window marked B (Figure 3.6). 
• The test device was allowed to stand for 15 minutes after which the results of the test were read. 
 
Figure 3.6  Validation and interpretation of HIV 1/2 Antibody test results on the Visitect test strip.  
Result Interpretation 
A positive HIV 1/2 Antibody test result was characterised by a pink line in both the control (C) and 
test (R) regions of the test device. If there was no pink line in the control region after 15 minutes, an 
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extra 15 minutes was allowed until the result was read again. If there was still no pink line in the 
control region after the additional 15 minutes, the test result was deemed as void and the sample was 
re-tested.  
A negative HIV 1/2 Antibody test result was characterised by a pink line in the control region and no 
line in the test region. An additional 15 minutes was allowed if the pink line was not visible in the 
control region after the initial 15 minutes. If there was no pink line in the control region after the 
additional 15 minutes, the test result was deemed as void and the sample was re-tested. 
3.5 OBJECTIVE 2  
a) To prospectively collect swab samples from both lungs and trachea from SUDI cases through the 
Forensic Pathology Division at Tygerberg Hospital for virological research purposes. 
b) To prospectively collect whole blood from SUDI cases for immunological research testing. 
In addition to the routine samples, swabs from the lungs and trachea were collected for virological 
analysis. The serum that was left over after routine HIV 1/2 antibody testing was used for research 
immunological analysis. 
3.5.1 Research virology samples 
Swabs from the trachea and both lungs were collected for virological investigations. The research 
lung swab samples were collected from the same incision made when collecting the routine lung swab 
samples. A flocculated swab (Copan Diagnostics, Italy; Lasec, Cape Town) was used to collect the 
research lung and tracheal swab samples. The infant’s neck tissue was exposed and dissected to 
expose the trachea. Using a sterile blade, the trachea was anteriorly excised between the sternal notch 
and thyroid gland. The distal tracheal end was then pulled upwards slightly to expose the lumen. The 
flocculated swab was then inserted into the open end and pushed downwards as far as possible. The 
swab was also rotated inside the trachea several times before being removed. Afterwards, these swabs 
were placed into a container with 3 ml UTM (Copan Diagnostics, Italy; Lasec, Cape Town) and 
transported to the Virology laboratory where these containers were pulse vortexed thirty times on a 
Heidolph vortex. The UTM containers had three glass beads at the bottom and these facilitated 
maximum sample recovery by constantly hitting the flocculated swabs during pulse vortexing. The 
recovered sample was aliquoted into two 1.5 ml microcentrifuge tubes (Whitehead Scientific, Cape 
Town) and stored at -80°C. 
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3.5.2 Research immunology samples 
Whole blood was collected as described in Section 3.4.4. After centrifugation, the serum was 
collected and stored at -80°C for later analysis. 
3.6 OBJECTIVE 3  
To extract viral nucleic acid (DNA and RNA) from lung tissue and lung and tracheal swabs. 
3.6.1 Sample Processing 
After collection and proper storage of samples, molecular and immunology assays were used to 
process the samples. Firstly, viral nucleic acid was extracted from lung and tracheal swabs. After the 
extraction, complementary DNA (cDNA) was synthesised from the nucleic acid extracts to stabilise 
the extracted RNA for long time storage. A multiplex PCR was conducted on the cDNA; followed 
by detection of amplified nucleic acid from target respiratory viruses by agarose gel electrophoresis. 
3.6.2 Viral nucleic acid extraction 
Lung and tracheal swab samples previously stored at -80°C were completely thawed at room 
temperature (20-25°C). After thawing, the samples were pulse vortexed 10 times on a Heidolph 
vortex. The extraction of viral nucleic acid (DNA and RNA) was conducted using the Qiagen Cador 
Pathogen Mini Kit (Whitehead Scientific, Cape Town) in accordance with the manufacturer’s 
instructions. In summary, 1.5 ml microcentrifuge tubes were labelled appropriately and 20 µl of 
proteinase K added. Afterwards, 200 µl of sample and 100 µl of lysis buffer VXL were added and 
the contents mixed thoroughly by pulse vortexing twenty times on a Heidolph vortex. After 15 minute 
incubation at room temperature, the tubes were centrifuged briefly and 350 µl of binding buffer ACB 
was added to the sample. The tubes were again pulse vortexed twenty times and then centrifuged 
briefly. The lysate was transferred to a QIAamp mini column placed in a 2 ml collection tube and 
centrifuged at 8 000 rpm for 1 minute. Thereafter, 600 µl of wash buffer AW1 was added to the mini 
column that had been placed in a new 2 ml collection tube. The mini column was centrifuged at 
8 000 rpm for 1 minute and the collection tube with flowthrough discarded. Afterwards, the mini 
column was placed in a new 2 ml collection tube and 600 µl of wash buffer AW2 added into the mini 
column, which was then centrifuged at 8 000 rpm for 1 minute. The column was then placed in a new 
2 ml collection tube and centrifuged again at 13 200 rpm for two and a half minutes to completely rid 
the column of residual ethanol. The mini column was then placed in a clean 1.5 ml microcentrifuge 
tube; 40 µl of elution buffer AVE added to the column and incubated at room temperature for one 
minute. The column was then centrifuged at 13 200 rpm for 90 seconds. 
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After the elution step, the yield and purity of the extracted nucleic acid were determined using the 
Nanodrop ND1000 instrument. The 260/280 values were used as a measure of purity of the extracts. 
For DNA, a 260/280 ratio close to 1.8 indicates high purity, while for RNA, a 260/280 ratio close to 
2.0 showed a highly pure extract. As such, extracts with 260/280 ratios within a range of 1.8 to 2.2 
were deemed suitably pure for downstream applications, while those out of range were re-extracted. 
After optimisation of the manufacturers’ extraction protocol, the following modifications were made:  
• Centrifugation to completely dry the mini column was conducted at 13 200 rpm for two and a half 
minutes as opposed to 14 000 rpm for two minutes. 
• The viral nucleic acid on the mini column was eluted in 40 µl of elution buffer as opposed to 50-
150 µl and centrifugation was conducted at 13 200 rpm for one and a half minutes as opposed to 
14 000 rpm for one minute. 
Optimisation 
In order to evaluate the success of the extraction method, a positive control of known identity was 
obtained from the NHLS Virology laboratory and extracted alongside the study samples. Multiplex 
PCR was then used to determine if it had been successfully extracted as shown in Figure 3.7. PBS 
was used as a negative control during extractions to identify possible cross contaminations. 
Result Validation 
A successful viral nucleic acid extraction procedure was characterised by the following criteria: 
• Positive control with a nucleic acid yield of ≥ 50 ng/μl and a 260/280 ratio between 1.8 and 2.2. 
• Correct identification of the known positive control by multiplex PCR as observed in the band 
circled in yellow (Figure 3.7, Panel MB, Lane 7). 
• The absence of a band in the negative control lane after multiplex PCR as shown in the band circled 
in red (Figure 3.7, Panel MB, Lane 10).  
In the event that any of the criteria above was not met, the results of the entire nucleic acid extraction 
procedure were disregarded and viral nucleic acid re-extracted from the same samples. 
Stellenbosch University  https://scholar.sun.ac.za
 38 
 
Figure 3.7 Validation of extraction and visualisation of multiplex PCR results using agarose gel 
electrophoresis. The yellow circle indicates a positive PCR internal control result and the 
red rectangle indicates a negative result in the negative control lane.  
3.7 OBJECTIVE 4 
To use the RevertAid first strand cDNA synthesis and Seeplex RV15 ACE detection kits to detect the 
presence of 15 respiratory viral targets in lung and tracheal swabs collected from SUDI cases. 
3.7.1 cDNA synthesis 
Nucleic acid, RNA in particular, degrades readily when stored for lengthy periods. Of the 15 
respiratory viruses targeted in this study, 13 were RNA viruses5. It was therefore necessary to convert 
extracted viral RNA to cDNA that is more stable when stored for extended periods. Prior to the cDNA 
synthesis, the extracted viral nucleic acid stored at -80°C was thawed at room temperature. After the 
nucleic acid had completely thawed, the RevertAid First Strand cDNA Synthesis Kit (Inqaba Biotec, 
Pretoria) was used to make the cDNA as per manufacturer’s instructions below. A cDNA synthesis 
mastermix was first prepared as indicated in Table 4.1 and stored at 4°C for later use. 
Table 3.1 cDNA synthesis mastermix 
REAGENT VOLUME 
5X RT buffer 4 µl 
10mM dNTP 2 µl 
RNase inhibitor 1 µl 
Reverse transcriptase 1 µl 
TOTAL VOLUME 8 µl 
 
                                                 
5 Enterovirus, HCoV OC43, 229E/NL63, Influenza A and B, MPV, PIV 1 - 4, Rhinovirus, RSV A and B 
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• 1 µl of random hexamer and 3 µl of DEPC-treated water was added to a 0.2 ml thin walled PCR 
tube (Whitehead Scientific, Cape Town) on ice.  
• 8 µl of extracted viral RNA was added last to the PCR tube, after which it was incubated for three 
minutes at 80°C on a GeneAmp PCR System 9700 thermocycler (Applied Biosystems, USA).  
• The PCR tube was then immediately chilled on ice for 2 minutes, after which the contents of the 
tube were briefly centrifuged on a Labnet minifuge (Whitehead Scientific, Cape Town).  
• The stored cDNA synthesis mastermix was taken out of temporary storage and 8 µl of it added to 
the PCR tube that had been placed on ice. 
• The contents of the tube were mixed by inverting the tube five times and then briefly centrifuged. 
• The tube was then incubated under the conditions shown in Figure 3.8. 
 
Figure 3.8  cDNA synthesis conditions 
The synthesised cDNA was stored at -20°C for later analysis. To ensure that no variability in results 
was introduced due to the usage of different thermocyclers, the same thermocycler was used for all 
cDNA synthesis steps. 
3.7.2 Seeplex RV15 ACE Multiplex detection PCR 
The detection of 15 target viruses6 in the extracted samples was done on cDNA using the Seeplex 
RV15 ACE detection kit (Seegene, Germany; Inqaba Biotec, Pretoria). The kit has three different 
panels; each panel composed of different viruses as shown in Table 3.2. 
Viruses can be detected in respiratory samples using various techniques that target different aspects 
of the virus. Some immunology-based assays are directed against viral particles or antibodies to that 
virus, while cell culture assays utilise the ability of viruses to grow in certain cell lines to produce 
characteristic morphology or CPE in the cells. The Seeplex RV15 ACE detection PCR kit enables the 
simultaneous amplification and detection of 15 viral targets in one sample. In order to conduct the 
multiplex detection PCR, the reagents were removed from -20°C storage and thawed on ice. The 
cDNA was also removed from -20°C storage and thawed at 4°C. Each sample was amplified in three 
                                                 
6 Adenovirus, Bocavirus, Enterovirus, HCoV OC43, 229E/NL63, Influenza A and B, MPV, PIV 1 - 4, Rhinovirus, RSV A and B 
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separate reactions simultaneously and as such, three 0.2 ml PCR tubes (Whitehead Scientific, Cape 
Town) were labelled for each panel and placed on a cold block. The thawed reagents were pulse 
vortexed and briefly centrifuged and the PCR mastermix prepared as indicated in Table 3.3. 
Table 3.2  Seeplex RV15 ACE viral target panels 
PANEL A PANEL B PANEL C 
HAdV HCoV OC43 HBoV 1/2/3/4 
HCoV 229E/NL63 HRV A/B/C Influenza B virus 
HPIV 2 RSV A HMPV 
HPIV 3 Influenza A virus HPIV 4 
HPIV 1 RSV B HEV 
  
Table 3.3  Seeplex RV15 ACE multiplex detection PCR 
REAGENT VOLUME 
5X RV15 ACE Primer Mix A/B/C 4 µl 
2X Multiplex Master Mix 10 µl 
8-MOP Solution 3 µl 
TOTAL VOLUME 17 µl 
 
The prepared mastermix was briefly vortexed and centrifuged and 17 µl pipetted into each of the 
0.2 ml PCR tubes. Afterwards, 3 µl of the thawed cDNA was added and pipetted up and down five 
times to ensure that the contents of the tubes were completely mixed. The 0.2 ml PCR tubes were 
then briefly centrifuged on a minifuge and cDNA amplified by placing the 0.2 ml PCR tubes in a 
GeneAmp PCR System 9700 thermocycler under the cycling conditions in Table 3.4: 
A positive control of known identity was supplied in the multiplex PCR kit and was included in every 
multiplex PCR run to serve as a validation of the amplification process. Nuclease free water was used 
as the template in the negative control tube, which was also included in every run to serve as an 
indicator of any possible contaminations in a particular multiplex PCR run. After completion of the 
Seegene Seeplex Multiplex Detection PCR, the PCR products were temporarily stored at 4°C. 
Table 3.4  Seeplex RV15 ACE Multiplex Detection PCR cycling conditions 
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SEGMENT NUMBER OF CYCLES TEMPERATURE DURATION 
1 1 94°C 15 min 
 
40 
94°C 0.5 min 
2 60°C 1.5 min 
 72°C 1.5 min 
3 1 72°C 10 min 
 
Detection of amplified viral targets 
The amplified viruses in the PCR product were identified using agarose gel electrophoresis. The 
method utilises an electrical current to migrate negatively charged nucleic acid fragments from the 
negative electrode to the positive electrode using a buffer solution as a conductor of electricity. 
Nucleic acid fragments from different viruses are of a different base pair (bp) size and hence migrate 
at different rates on the agarose gel. After a while, these different sized fragments separate and are 
identified by comparison to molecular weight markers which are reference fragments of known size 
and identity. Agarose gel electrophoresis was conducted on a 2% agarose gel as follows: 
• 2 g of agarose powder (Whitehead Scientific, Cape Town) were weighed and placed into a 500 ml 
glass container. 
• The agarose powder was then dissolved in 100 ml of 1X Tris acetate EDTA (TAE) buffer by 
heating the mixture in a microwave for two minutes. 
• The agarose was sufficiently cooled down under running tap water and poured into a moulding 
tray where it solidified over 25 minutes. 
• 1X TAE buffer was then poured onto the solidified 2% agarose gel. 
• 5 µl of the three different molecular weight markers (one for each panel of viruses) from the 
Seeplex RV15 ACE detection kit were mixed with a drop of novel juice (Whitehead Scientific, 
Cape Town) by pipetting up and down five times before being loaded onto the agarose gel. 
• 5 µl of the PCR products were also loaded with a drop of novel juice. 
• The agarose gel was covered with a lid and connected to a power supply where the gel was run at 
65V for 56 minutes.  
• Afterwards, the fluorescence on the agarose gel produced by PCR products bound to novel juice 
was visualised using ultraviolet light on a UVITEC Cambridge gel dock system. 
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Validity of results 
Seeplex RV15 ACE multiplex detection PCR results were only deemed valid if: 
• The internal control band was visualised in the positive and negative control lanes (18 and 19 
respectively on Figure 3.9). 
• The positive control lane had five other fluorescing bands besides the internal control. 
• The negative control lane had no other fluorescing band except the internal control. 
 
Figure 3.9  Internal control band for PCR validation 
In the event that any of the criteria above was not met, the PCR results were deemed as void and the 
multiplex PCR was repeated from the start.  
Result interpretation 
The gel image obtained from the UVITEC Cambridge gel dock system is analysed by comparing the 
amplicon sizes seen on the gel image (Figure 3.10) with target virus amplicon sizes in Figure 3.11.  
 
Figure 3.10  Interpretation of gel image results 
The viral screening results as seen on Figure 3.10 would be as follows: 
• Sample 1 – Negative for all viruses in Panel A and B. 
• Sample 2 – Negative for all viruses in Panel A and positive for Human Rhinovirus A/B/C. 
• Sample 7 – Negative for all viruses in Panel A and positive for Human Rhinovirus A/B/C. 
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• Sample 9 – Positive for HAdV and Human Rhinovirus A/B/C. 
• Sample 13 – It is the positive control and bands amplified, hence PCR reaction worked. 
• Sample 14 – It is the negative control and only the internal control band was seen as expected. 
 
Figure 3.11  Target virus amplicon sizes 
3.8 OBJECTIVE 5 
To measure CRP levels in serum from all SUDI cases prospectively collected between July 2015 and 
June 2016 as an indicator of infection and inflammation prior to or at the time of death of the infant. 
3.8.1 Serum CRP quantification 
Serum CRP was quantified using a DRG high sensitivity CRP ELISA (Biocom Biotech, Cape Town). 
Prior to use, the kit was removed from 4°C storage and allowed to reach room temperature. Serum 
samples previously stored in 1.5 ml microcentrifuge tubes were also removed from -80°C storage and 
allowed to completely thaw at room temperature. Afterwards, the serum was pulse vortexed five times 
on a Heidolph vortex and then centrifuged in a 5415D Eppendorf centrifuge at 3 000 rpm for 1 minute 
to move any serum on the lid to the bottom of the tube.  
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The quantification of CRP was then conducted according to the manufacturer’s instructions as 
follows: 
• Serum was diluted 100 fold in a 1.5 ml microcentrifuge tube by mixing 5 µl of serum with 495 µl 
sample diluent provided in the kit, pulse vortexed five times and then briefly centrifuged. 
• The desired number of mouse monoclonal anti-CRP antibody coated wells were secured in the 
holder. 
• 10 µl of the each of the six CRP standards provided in the kit was dispensed in duplicate into the 
appropriate wells. 
• 10 µl of diluted specimens and controls were then dispensed into the appropriate wells. 
• 100 µl of CRP Enzyme Conjugate Reagent were then dispensed into each of the wells, after which 
the contents of the wells were thoroughly mixed by gentle shaking for 30 seconds. 
• The reaction mixture was then incubated at 20°C for 45 minutes. 
• Afterwards, the incubation mixture was removed by flicking the plate contents into a waste 
container. The plate was then washed five times with distilled water on an automated Tricontinent 
Multiwash II plate washer.  
• The wells were also struck sharply onto absorbent material to ensure complete removal of residual 
water droplets. 
• 100 µl of TMB solution (a chromogenic visualising agent) were dispensed into all the wells and 
the well contents mixed for five seconds by gently shaking the plate. 
• The reaction was then incubated at 20°C for 20 minutes. 
• After incubation, the reaction was stopped by adding 100 µl of Stop Solution to each well and the 
plate gently shaken for 30 seconds until all blue colour turned completely yellow.  
• The absorbance of the samples was read on a Worldwide Diagnostics microplate reader at 450nm 
within 15 minutes and the concentration of CRP in the samples automatically determined from the 
standard curve. 
3.9 OBJECTIVE 6 
To measure levels of 15 cytokines and chemokines in serum samples collected from all SUDI cases 
admitted to the Tygerberg Medico-Legal Mortuary between July 2015 and June 2016 as an indicator 
of infection and inflammation prior to or at the time of death of the infant. 
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3.9.1 Serum immune biomarkers screening 
A customised, magnetic Luminex® screening assay (R&D Biosystems, USA; Whitehead Scientific, 
Cape Town) was used to screen for the 15 cytokines and chemokines in Table 3.5.  
Table 3.5  Analytes included in a customised, magnetic Luminex screening assay 
TARGET ANALYTES 
IL-1 alpha IL-6 IL-23 
IL-1 beta IL-8 IFN-gamma 
IL-2  IL-10 IL-1RA 
IL-4 IL-12 IP-10 
IL-5 IL-18 TNF-alpha 
 
The serum was taken from storage at -80°C and allowed to thaw completely at room temperature. 
The kit was also taken from storage at 4°C and brought to room temperature prior to use. Once the 
kit components had reached room temperature, reagents were prepared as follows: 
Assay Standards 
• Each of the three standard cocktails provided in the kit was reconstituted by adding 100 ml of 
Calibrator Diluent RD6-52 and allowed to stand for 15 minutes at room temperature with gentle 
agitation by finger tapping of the bottom of the container.  
• 100 µl from each of the three reconstituted standard cocktails were pipetted into a single 1.5 ml 
microcentrifuge tube (Whitehead Scientific, Cape Town). 700 µl of Calibrator Diluent RD6-52 
was added to make a final volume of 1 ml for Standard 1. 
• 200 µl of Calibrator Diluent was added to each of the 1.5 ml microcentrifuge tubes labelled 
Standard 2-6.  
• Standard 1 was then used to make a 3-fold dilution series by pipetting 100 µl of Standard 1 into 
the tube labelled Standard 2. The solution was mixed by pipetting up and down five times and 
100 µl pipetted into the tube labelled Standard 3 from the Standard 2 tube. This process was 
repeated up to the tube labelled Standard 6 as shown in Figure 3.127. 
                                                 
7 https://resources.rndsystems.com/pdfs/datasheets/lxsahm.pdf 
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Diluted Microparticle Cocktail  
• The microparticle cocktail vial was centrifuged in a microcentrifuge for 30 seconds at 1 000 g and 
then gently pulse vortexed to resuspend the microparticles.  
• The microparticle cocktail was then diluted in a mixing bottle provided by adding 2.5 ml of Diluent 
RD2-1 to 250 µl of the microparticle cocktail. This was prepared 30 minutes before use. 
 
Figure 3.12  Dilution series for standard preparation 
Biotin Antibody Cocktail 
• The biotin antibody cocktail vial was centrifuged in a microcentrifuge for 30 seconds at 1 000 g 
and gently vortexed.  
• The cocktail was then diluted by adding 2.5 ml of Diluent RD2-1 to 250 µl of the biotin antibody 
cocktail and gently tapping the bottom of the tube to mix. 
Streptavidin-PE 
• The Streptavidin-PE vial was centrifuged for 30 seconds at 1 000 g and gently vortexed, followed 
by dilution to a 1X concentrate by adding 2.68 ml of Wash Buffer to 110 µl of Streptavidin-PE 
concentrate.  
• The dilution was conducted in a polypropylene test tube wrapped with aluminium foil. 
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Wash buffer 
• 20 ml of Wash Buffer concentrate were added to 480 ml of distilled water in a sterile glass 
container and thoroughly mixed by shaking. 
Assay Procedure 
• The diluted microparticle particles were resuspended by pulse vortexing three times and then 50 µl 
pipetted into each of the wells on the flat bottom, 96 well plate (Bio-Rad, Johannesburg). 
• 50 µl of the Standards were added to the appropriate wells in duplicate, starting from Standard 1 
up to Standard 6 with Calibrator Diluent RD6-52 acting as the blank. 
• Completely thawed, undiluted serum samples were pulse vortexed, microcentrifuged for 1 minute 
at 2 000 rpm and 50 µl of the serum pipetted into the appropriate wells. 
• The plate was then securely covered with foil plate sealer provided and incubated for two hours at 
room temperature on a horizontal orbital microplate shaker set at 800 rpm. 
• After incubation, the plate was washed on a magnetic plate washer by filling each well with 100 µl 
wash buffer and completely removing the liquid from the well. This was repeated three times. 
• 50 µl of the diluted biotin antibody cocktail was added to each well and the plate securely covered 
with a foil plate sealer. The plate was incubated for one hour at room temperature on a shaker set 
at 800 rpm. 
• After incubation, the plate was washed as before and 50 µl of the diluted Streptavidin-PE added 
to each well. The plate was again securely covered with a foil plate sealer and incubated for 30 
minutes at room temperature while shaking at 800 rpm on a plate shaker. 
• Washing was then conducted as before and the microparticles resuspended by adding 100 µl of 
wash buffer to each well. The plate was incubated again for 2 minutes at room temperature while 
shaking at 800 rpm. 
• Finally, the plate was read on a Bio-Rad Bio-Plex analyser and the concentrations of each of the 
15 analytes automatically determined by the instrument. 
3.10 Data Stratification 
All data was captured in Microsoft Excel®. The entire dataset was statistically analysed and measures 
of occurrence are reported as frequencies, proportions and ratios. Numerical data is reported as Mean 
± SD, range and Median where applicable. 
Stellenbosch University  https://scholar.sun.ac.za
 48 
The dataset was stratified according to known risk factors and compared according to gender, age 
(< 8 weeks, 9-16 weeks, > 16 weeks), season, housing, sleeping position, as well as COD 
classification.  
3.11 Statistical Analyses 
The chi-square test was used to compare observations between the two COD classifications (SIDS 
and infection). When the criteria of this test were not met (observations less than 5 in one or more 
groups), the Fischer test was used. 
To compare medians between the two cause of death groups, the non-parametric test, Mann Whitney 
was used. A simple logistic regression was used to measure the strength of the association between 
independent and dependent variables.  
All variables displaying a p-value less than 0.1 in bivariate analyses were used to build a multivariate 
logistic model predicting the likelihood of SUDI being diagnosed as infection. Results of this model 
were reported as adjusted odds ratio (aOR) and corresponding 95% CI. The p-value cut-off point was 
0.05.  
All statistical analyses were performed with IBM SPSS statistical software with the assistance of the 
Centre for Statistical Consultation at the Tygerberg Campus. 
The raw data is attached as Addendum A2.  All non-numeric fields were coded to facilitate 
comparison between pre-defined groups. 
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CHAPTER 4: RESULTS 
Different types of samples were collected from 183 SUDI cases admitted to the Tygerberg Medico-
Legal Mortuary between July 2015 and June 2016 for the purposes of this study. This included the 
left and right lung and trachea swabs for virological analysis by targeting 15 respiratory viruses with 
the Seeplex RV15 ACE multiplex PCR detection kit. Additionally, serum was collected to determine 
the PM levels of 16 pro- and anti-inflammatory immune biomarkers of infection. The sample 
collection was done over a 12 month period to include all seasons, due to the seasonal variations 
observed in SUDI cases. For routine laboratory analysis of specimens by the NHLS diagnostic 
laboratory, lung and liver tissue were collected for centrifugation-enhanced SVC, while left and right 
lung and heart swabs were collected for microbiological culture and detection of microorganisms. 
Two more small pieces of the right and left lungs were used for histological examination of tissue for 
signs of infection. Serum was used for the detection of HIV 1/2 antibodies. 
4.1 Study population characteristics 
A total of 183 SUDI cases admitted to the Tygerberg Medico-Legal Mortuary were included in the 
study. The study group comprised 90 (49.1%) males and 93 (50.9%) females with a male : female 
ratio of 1:1.03. Not all the information was always captured on the questionnaires, but we will report 
on the number of cases that were available. There were several reasons for incomplete capture of 
information. Some parents or caregivers were too traumatised to answer questions, while others were 
not available (for reasons unknown to the research team). Furthermore, different forensic pathology 
officers were conducting the interviews according to their shifts, resulting in non-standardised replies. 
The age was available for 170 of the cases and the average age was 13.5 ± of 12.8 weeks. The median 
age was 9 weeks with a range between 0.3 and 52 weeks. Quite a high percentage of the infants (39%) 
weighed less than 2 500 g at birth, which was regarded as low birthweight, with 22% having extreme 
low birthweight (< 2 000 g at birth). We did not collect any information about the gestational age of 
the infants, and can therefore not conclude if any of these low birthweight infants were premature as 
well. 
The period between June and November was regarded as the cold season, while December to May 
was regarded as the warm season. A total of 123 cases occurred in the cold season, compared to 60 
in the warm season. Interestingly, more female infants than males died in the colder months, while 
more male infants than females died in the warmer months as shown in Figure 4.1. 
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Figure 4.1  Distribution of SUDI cases by gender and season 
The racial distribution (Figure 4.2) showed a majority of black infants (109, 60%), compared to 61 
(33%) coloured infants. In the remaining 13 (7%) cases, no race was specified in the case files. No 
infants from other racial groups were admitted to the Tygerberg Medio-Legal Mortuary during the 
study. 
The average PMI in this study was 4.6 ± 2.6 days (range 0 – 19 days). There were only a few instances 
where the PM was conducted after 14, 16, 17 and 19 days, which could have been as a result of bodies 
not being promptly identified and claimed by the infants’ relatives. However, these outliers were the 
exception, because a Median of 4 days was reported. 
Other sociodemographic information of note was bed-sharing which was reported in 96/101 cases 
(95%), while 64/114 (56%) reportedly lived in informal housing. Exposure to cigarette smoke from 
parents was less common than expected in only 35/113 (31%) and the use of alcohol was only 
reported in 22/113 (20%). In 55/183 (30%) of the cases, clinical symptoms were reported to be present 
immediately prior to their demise. The majority of these reported symptoms included flu-like or 
respiratory symptoms. However, these were not confirmed by a medical professional and were not 
included in the statistical analyses of the data. 
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Figure 4.2  Racial distribution of cases included in the study 
The sleeping position of infants received much attention in the literature and our results showed that 
37/101 (37%) of infants were put to sleep on their stomach, 54/101 (53%) on their side and 10/101 
(10%) on their backs, while a similar trend was evident for the position in which the infants were 
found, i.e. 38/137(28%), 63/137 (46%) and 34/137 (25%) on their stomach, side and back 
respectively. No data was available for 2 of the cases. 
It is important to note that this data is based on the information that the parents or individual(s) give 
when being interviewed at the time when the infants are admitted to the Tygerberg Medico-Legal 
Mortuary and is very likely to be biased. 
4.2 Routine microbiology results 
Microbiological culture was conducted on the heart and left and right lung swabs to detect 
microorganisms, such as bacteria that might have been present prior to the death of the infant. Culture 
results were only available for 161/183 (88%) cases. The most commonly detected microorganisms 
were Escherichia coli and Klebsiella pneumoniae, followed by Haemophilus influenzae, 
Enterococcus faecalis, Strep pneumoniae and Raoultella planticola (Table 4.1). The majority of other 
bacterial species were only detected in a single case. 
109, 60%61, 33%
13, 7%
Black
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Table 4.1  The prevalence of different bacterial species in routine microbiological culture 
Identity of bacteria Number of positive cases (n=161) 
Candida parapsilosis 1 (0.6%) 
Enterococcus avium 1 (0.6%) 
Escherichia coli 20 (12.4%) 
Enterococcus faecalis 10 (6.2%) 
Enterococcus faecium 1 (0.6%) 
Haemophilus haemolyticus 1 (0.6%) 
Haemophilus influenzae 10 (6.2%) 
Klebsiella oxytoca 5 (3.1%) 
Klebsiella pneumoniae 20 (12.4%) 
Lactococcus gaviae 1 (0.6%) 
Lactobacillus spp 1 (0.6%) 
Moraxella group 1 (0.6%) 
Proteus mirabilis 1 (0.6%) 
Raoultella planticola 7 (4.3%) 
Streptococcus agalactiae 2 (1.2%)  
Staphylococcus aureus 6 (3.7%) 
Streptococcus gallolyticus 1 (0.6%) 
Streptococcus mitis/oralis 2 (1.2%) 
Skrjabinema ovis 1 (0.6%) 
Streptococcus pneumoniae 8 (5%) 
Streptococcus pyogenes 2 (1.2%) 
Streptococcus viridans 1 (0.6%) 
βeta-haemolytic streptococcus 3 (1.9%) 
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Of the 161 heart swab samples that were cultured, 106 (66%) were negative. This was in contrast to 
the left and right lung swabs where negative results were found in 68 (42%) and 66 (41%) cases 
respectively. No bacteria could be detected in any of the three swabs in 48 (29%) of cases. However, 
some microorganism growth that was observed in culture, was characterised as PM flora in 32 (20%) 
cases. 
4.3 COD classification 
At the time of final data analyses, only 118 (64%) cases were signed out with a final COD by the 
forensic pathologists. Investigations to determine the COD were ongoing for the other 65 (36%) 
cases, which were still under investigation at the time of statistical analysis and write-up of this thesis. 
In defining or classifying the COD in these cases, pathologists only considered results from the 
routine SVC and microbiological culture performed by the NHLS diagnostic laboratories, as well as 
histological analysis of lung tissue for signs of infection.  
The COD classification in this study was divided into three categories, i.e. Infection, SIDS and Other 
(Figure 4.3). Thirty-four (29%) deaths were as a result of infection, while SIDS was assigned the final 
COD in 57 (48%) and 27 (23%) of the deaths were classified as other. The other category included 
death was confirmed to be a result of aspiration of gastric contents, asphyxia or atrial septal defects. 
 
Figure 4.3  Final COD distribution in 118 cases as determined by forensic pathologists 
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4.4 Comparison of routine SVC with Multiplex PCR results 
As illustrated in Table 4.2, multiplex PCR was able to detect a virus in considerably more cases 
compared to SVC. In addition, multiplex PCR was able to detect all viral targets except HMPV in at 
least one case, while SVC could only detect one of its nine viral targets, i.e. CMV.  
Table 4.2  Comparison of the number of cases in which a viral target was detected by multiplex 
PCR or shell vial culture 
Viral Target Multiplex PCR Shell Vial Culture 
Adenovirus 18 0 
Bocavirus 1/2/3 3 Not included in panel 
Cytomegalovirus Not included in panel 13 
Coronavirus 229E/NL63 3 Not included in panel 
Coronavirus OC43 3 Not included in panel 
Enterovirus 9 Not included in panel 
Influenza A 4 0 
Influenza B 1 0 
Metapneumovirus 0 0 
Parainfluenza virus 1 1 0 
Parainfluenza virus 2 1 0 
Parainfluenza virus 3 10 0 
Parainfluenza virus 4 1 Not included in panel 
Rhinovirus A/B/C 65 Not included in panel 
Respiratory Syncytial Virus A 2 0 
Respiratory Syncytial Virus B 7 0 
 
4.5 Multiplex PCR result breakdown 
Respiratory virus detection in this study utilised the Seeplex RV15 ACE multiplex PCR detection kit. 
According to Table 4.1, the most commonly detected virus was HRV A/B/C, which was detected in 
65 (36%) of the 183 cases tested. HAdV was the second most frequently detected virus in 18 (10%) 
of the cases tested. PIV 3, HEV and RSV B were detected in 10 (6%), 9 (5%) and 7 (4%) cases 
respectively. HMPV was the only virus that was not detected in any of the 183 cases. It was interesting 
to note the majority of virus positive samples were swabs collected from the trachea and not from the 
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lung swab samples. It is only in a few cases where the lung swabs were positive for a virus that was 
not detected in the tracheal swab of the same case. The reason for this is currently not known. 
4.6 Serum immune biomarker testing results  
Epidemiological data was not always available from the SUDI case files. The same was true for serum 
samples for different reasons. At times, there was not enough serum left after conduction of routine 
HIV 1/2 antibody testing by the NHLS Virology laboratory. In other instances during the autopsy, 
the forensic officers were unable to extract blood from the infant’s heart.  
Quantification of immune biomarkers was only performed in cases where sufficient serum was 
available and the descriptive statistical analyses are summarised in Table 4.3.  
Table 4.3 Results of individual immune biomarker concentrations in pg/ml 
Target analyte N Mean SD Median Min Max 
IFN-γ 135 224.75 770.02 3.28 0.00 5 873.30 
IL-1α 135 15.68 37.74 5.83 0.00 266.52 
IL-1β 135 364.77 1 440.20 86.38 0.00 12 892.00 
IL-1RA 135 11 148.00 7 581.70 9 090.00 1 328.60 46 649.00 
IL-2 135 382.51 812.95 115.77 0.00 6 830.60 
IL-4 135 250.45 2 044.30 32.98 0.00 23 792.00 
IL-5 135 2.71 6.57 0.41 0.00 41.80 
IL-6 135 591.02 2 669.80 13.31 0.00 22 733.00 
IL-8 135 320.69 721.47 70.56 6.27 5 411.60 
IL-10 135 3.14 9.13 0.00 0.00 72.32 
IL-12p70 135 97.93 282.13 0.00 0.00 1 640.20 
IL-18 135 328.78 372.87 232.50 0.00 2 255.50 
IL-23 135 479.81 929.38 202.51 0.00 7 293.30 
IP-10 135 93.56 195.32 46.89 0.00 2 074.90 
TNF-α 135 18.25 40.16 3.46 0.00 273.32 
CRP 139 3.69 4.91 1.50 0.00 18.65 
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4.7 Statistical analyses of serum immune biomarker data 
The hypothesis tested in Table 4.4 was that socio-demographic factors, such as age, bed-sharing, 
maternal smoking, sleeping position, race and season play a role in the ultimate diagnosis of SUDI to 
be a result of infection. However, no statistically significant differences  were found in the Infection 
and SIDS/Other groups for any of the socio-demographic factors being tested in this study. As such, 
none of these factors could be associated with the eventual COD being infection.  
The median values of immune biomarkers in cases where the COD was infection were compared to 
the median values in cases where the final COD was SIDS/other using the two-sample Wilcoxon test 
(Table 4.5). Only two biomarkers, IL-6 (p=0.012) and IL-18 (p=0.044) were statistically significant 
in their usefulness as guides to the possibility of a SUDI case being diagnosed as an infection. 
As summarised in Table 4.6, IL-1β (p=0.014) and IL-6 (p=0.016), there is statistical significance for 
the two biomarkers to be used as a predictor for SUDI being as a result of infection as opposed to 
SIDS/other when their concentration in serum is above the set thresholds of 80 pg/ml and 16.5 pg/ml 
respectively. 
The hypothesis tested in Table 4.7 was also that socio-demographic factors, such as age, gender, 
season, sleeping position and housing play a role in the ultimate diagnosis of SUDI being as a result 
of infection. As summarised in Table 4.7, cold season (p=0.064) showed a trend towards statistical 
significance with the eventual diagnosis of a SUDI case being infection in this study and as such was 
a candidate for multivariate regression analysis, results of which are shown in Table 4.8. 
Upon comparing the median values of biomarkers in SUDI cases where infection was the cause of 
death with the median values for the same biomarkers in cases with a SIDS diagnosis (Table 4.8), IL-
6 (p=0.002) was statistically significant to be considered as a useful marker in diagnosing SUDI as 
having an infectious cause. The other biomarkers, IL-1β, IL-6, IL-8, IL-18 and CRP, by virtue of 
having a p-value >0.05 but less than 1 were candidates for multivariate logistic regression analysis 
(Table 4.8). 
A multivariate logistic regression as shown in Table 4.9 was done to ascertain the effects of CRP, IL-
6, IL-8, IL-1β, IL-18 and the cold season on the likelihood of SUDI being diagnosed as infection. 
Statistical significance was demonstrated for CRP (p=0.039) and IL-18 (p=0.011).  
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Table 4.4  Socio-demographic factors associated with the cause of death in SUDI being diagnosed 
as infection compared to a SIDS diagnosis or other diagnoses 
  
SIDS / Other Infection 
p-value OR 95% CI 
N (%) N (%) 
Age (weeks)           
< 22  45 (90.0) 25 (78.1) 0.137 0.34 0.08 – 1.24 
≥ 22  5 (10.0) 7 (21.9)       
Alcohol Usage           
Yes 13 (19.7) 7 (18.9) 0.923 0.95 0.32 – 2.59 
No 53 (80.3) 30 (81.1)       
Bed-sharing           
Yes 57 (96.6) 27 (90.0) 0.330 0.31 0.03 – 2.01 
No 2 (3.4) 3 (10.0)       
Gender           
Male 57 (51.8) 23 (46.0) 0.495 0.79 0.40 – 1.54 
Female 53 (48.2) 27 (54.0)       
Housing           
Informal 27 (40.9) 19 (51.4) 0.306 1.52 0.67 – 3.45 
Formal 39 (59.1) 18 (48.6)       
Race           
Coloured 36 (36.0) 16 (32.7) 0.687 0.86 0.41 – 1.76 
Black 64 (64.0) 33 (67.3)       
Season           
Cold 74 (67.3) 40 (80.0) 0.099 1.94 0.89 – 4.51 
Warm 36 (32.7) 10 (20.0)       
Sleeping position           
Side 31 (50.8) 16 (57.1) 
0.576 
0.77 0.19 – 3.39 
Stomach 24 (39.3) 8 (28.6) 0.50 0.11 – 2.36 
Back 6 (9.8) 4 (14.3)     
Maternal smoking           
Yes 21 (31.8) 9 (24.3) 0.421 0.68 0.26 – 1.68 
No 45 (68.2) 28 (75.7)       
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Table 4.5  Immune biomarkers associated with a diagnosis of infection being made in SUDI cases  
Target analyte SIDS / Other (N=84) Infection (N=34) 
p-value 
  Median (IQR) Median (IQR) 
IFN-γ 6.83 (1.13 – 26.76) 2.80 (1.37 – 27.80) 0.810 
IL-1α 5.86 (1.30 – 13.50) 6.17 (2.56 – 12.74) 0.725 
IL-1β 78.01 (43.71 – 172.02) 109.81 (72.16 – 168.94) 0.142 
IL-1RA 9 090.00 (9 033.35 – 11 161.84) 9 090.00 (9 090.00 – 12 604.25) 0.509 
IL-2 106.98 (30.84 – 322.35) 91.10 (19.71 – 267.02) 0.745 
IL-4 32.51 (14.30 – 90.89) 22.95 (7.32 – 63.22) 0.296 
IL-5 1.28 (0.00 – 1.94) 0.20 (0.00 – 1.94) 0.386 
IL-6 9.02 (2.86 – 59.25) 53.75 (10.18 – 383.54) 0.012 
IL-8 64.01 (37.95 – 213.19) 107.76 (40.80 – 406.32) 0.139 
IL-10 0.00 (0.00 – 2.82) 0.00 (0.00 – 2.51) 0.991 
IL-12p70 0.00 (0.00 – 49.76) 8.71 (0.00 – 23.14) 0.503 
IL-18 259.15 (113.57 – 486.02) 170.06 (20.53 – 297.98) 0.044 
IL-23 193.08 (61.17 – 446.57) 165.53 (44.62 – 490.69) 1.000 
IP 10 42.50 (0.00 – 73.52) 89.82 (3.97 – 162.86) 0.153 
TNF-α 4.29 (0.00 – 14.63 3.05 (0.00 – 9.57) 0.305 
CRP 1.40 (0.00 – 4.17)* 2.35 (0.10 – 9.05)** 0.193 
*  N=87      **  N=35 
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Table 4.6  A comparison of immune biomarker levels found in the two SUDI cause of death 
categories  
Target analyte 
SIDS / Other Infection 
p-value OR 95% CI 
N (%) N (%) 
CRP (mg/l)           
>0.35 53 (60.9) 25 (71.4) 0.274 1.60 0.69 – 3.88 
<0.35 34 (39.1) 10 (28.6)       
IFN-γ (pg/ml)           
>15.5 64 (76.2) 26 (76.5) 0.974 1.01 0.40 – 2.71 
<15.5 20 (23.8) 8 (23.5)       
IL-1β (pg/ml)           
>80 41 (48.8)) 25 (73.5) 0.014 2.91 1.25 – 7.28 
<80 43 (51.2) 9 (26.5)       
IL-6 (pg/ml)           
>16.5 34 (40.5) 22 (64.7) 0.016 2.69 1.19 – 6.32 
<16.5 50 (59.5 12 (35.3)       
IL-10 (pg/ml)           
>5.5 9 (10.7) 3 (8.8) 1 0.80 0.17 – 2.91 
<5.5 75 (89.3) 31 (91.2)       
TNF-α (pg/ml)           
>3.5 46 (54.8) 12 (35.3) 0.055 0.45 0.19 – 1.01 
<3.5 38 (45.2) 22 (64.7)       
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Table 4.7  Socio-demographic factors associated with the cause of death in SUDI being diagnosed 
as infection compared to a diagnosis of SIDS 
  SIDS Infection OR 95% CI p-value 
Gender           
Male 49 (68.1) 23 (31.9) 0.852 0.430 - 1.686 0.645 
Female 49 (64.5) 27 (35.5)       
Age           
< 8 weeks 21 (60.0) 14 (40.0) 0.711 0.251 -2.015 0.206 
9 – 16 weeks 19 (67.9) 9 (32.1) 2.250 0.655 - 7.734   
> 16 weeks 6 (40.0) 9 (60.0)       
Season           
Cold 64 (61.5) 40 (38.5) 2.125 0.947 - 4.768 0.064 
Warm 34 (77.3) 10 (22.7)       
Housing           
Informal 34 (65.4) 18 (34.6) 0.724 0.318 - 1.649 0.442 
Formal 26 (57.8) 19 (42.2)       
Sleeping position           
Stomach 23 (74.2) 8 (25.8) 0.522 0.117 - 2.337 0.556 
Side 28 (63.6) 16 (36.4) 0.857 0.210 - 3.498   
Back 6 (60) 4 (40)       
 
 
 
  
Stellenbosch University  https://scholar.sun.ac.za
 61 
Table 4.8  Immune biomarkers associated with a diagnosis of infection being made in SUDI 
compared to SIDS 
Target analyte 
SIDS (N=74) 
Median (IQR) 
Infection (N=34) 
Median (IQR) 
p-value 
IFN-γ 2.90 (0 – 24.42) 2.80 (1.37 – 27.80) 0.854 
IL-1α 5.89 (1.30 – 13.36) 6.17 (2.56 – 12.74) 0.630 
IL-1β 77.44 (41.23 – 161.20) 109.81 (72.16 – 168.94) 0.095 
IL-1RA 9090 (8920.05 – 11702.01) 9090 (9090 – 12604.25) 0.689 
IL-2 111.34 (33.90 – 315.46) 91.1 (19.71 – 267.02) 0.698 
IL-4 32.51 (14.30 – 92.15) 22.95 (7.32 – 63.22) 0.381 
IL-5 0.41 (0 – 1.94) 0.20 (0 – 1.94) 0.666 
IL-6 7.94 (2.63 – 28.68) 53.75 (10.18 – 383.54) 0.002 
IL-8 61.22 (34.33 – 102.63) 107.76 (40.80 – 406.32) 0.061 
IL-10 0 (0 – 2.66) 0 (0 – 2.51) 0.858 
IL-12p70 0 (0 – 33.23) 8.71 (0 – 23.14) 0.432 
IL-18 259.15 (111.65 – 444.4) 170.06 (20.53 – 297.98) 0.058 
IL-23 178.32 (52.4 – 419.94) 165.53 (44.62 – 490.69) 0.860 
IP 10 43.04 (24.35 – 74.83) 89.82 (3.97 – 162.86) 0.178 
TNF-α 3.90 (0 – 13.17) 3.05 0.476 
CRP 1.00 (0 – 3.85)* 2.35 (0.1 – 9.05)** 0.099 
*  N=77      **  N=35 
 
 
 
Table 4.9  Multiple logistic regression to ascertain the effect of select immune biomarkers and the 
cold season on the likelihood of SUDI being diagnosed as infection. 
Parameter aOR 95% CI p-value 
CRP 1.117 1.006 - 1.242 0.039 
IL-6 1.000 0.999 -1.001 0.956 
IL-8 1.000 0.999 - 1.002 0.541 
IL-1β 1.000 0.998 - 1.002 0.957 
IL-18 0.998 0.996 - 0.999 0.011 
Season (cold) 2.830 0.943 - 8.492 0.064 
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CHAPTER 5: DISCUSSION 
5.1 Overview 
Close to six decades after the idea of SIDS was introduced, a lot of research has been done and 
continues to be done to further understand the pathogenesis of SIDS. Through epidemiological 
studies, a number of risk factors for SIDS were identified. These include the infant’s sleeping position 
(prone-sleeping position), bed-sharing, poor socio-economic background, maternal smoking, colder 
seasons, gender and age (Morris, 1999; Raza & Blackwell, 1999; Vennemann et al., 2007; Fleming 
et al., 2015). An established and well-known risk factor for sudden infant death is cold weather; a 
time when infants are exposed to and often infected with respiratory viruses, such as HRV, which 
was detected in 35.5% of the cases investigated in this study. However, no association could be found 
between cold weather and a final COD of infection or SIDS. 
Infants, especially between the ages of two to four months old, are at a stage in their life where they 
are particularly susceptible to infection by viruses and bacteria. It is at this stage that they start to lose 
the maternal antibodies that constituted their defence against these organisms up to this point in their 
lives. It is also at this age that the incidence of SUDI is at its highest. In this study, of the 170 infants 
whose age was available, about a third of cases were aged between two and four months with more 
males (52%) than females (48%). Although the difference was small, the observation was in 
agreement with published literature, which suggests that male infants are at a greater risk of 
succumbing to SUDI as opposed to their female counterparts (Moscovis et al., 2014). However, our 
data showed that infants who died between 8 and 16 weeks (2 to 4 months) of age did not have a 
statistically significant chance of dying as a result of infection when compared to infants of the same 
age whose deaths were classified as SIDS.  
When Bruce Beckwith and his colleagues defined the term “sudden infant death syndrome” in 1969, 
there was so much controversy surrounding the subject (Beckwith, 1970; Bajanowski et al., 2006). 
The term SIDS described infant deaths where an adequate cause of death could not be determined 
after thorough investigations had been conducted (Krous et al., 2004). Even after conduction of 
thorough investigations involving death scene investigations, autopsies and review of the medical 
history, a larger number of sudden unexpected infant death cases remain unsolved and are finally 
diagnosed as SIDS. This was also the case in this study where almost half of the cases were classified 
as SIDS. If the cause of death in so many cases continues to elude investigators, it is reasonable to 
assume that the SIDS conundrum will be around for many more years. 
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5.3 Routine virology 
In our setting, routine virology involves centrifugation-enhanced SVC of lung and liver tissue and 
detection of viruses using immunofluorescence. This was done for all 183 SUDI cases, but SVC was 
only able to detect CMV out of a possible nine viruses and only in a very few cases. This could be a 
result of the 4-5 day PMI or inadequate transport and storage of samples. However, all the tissue 
samples were placed in preservation media immediately after collection and transportation to the 
laboratories within 10 minutes after collection, making the second scenario highly unlikely. When 
there is a time lapse between death and collection and culture of the tissue, there might be a loss of 
virus viability and the virus might fail to grow in culture. Interestingly, all but two cases in which 
CMV was detected had an average PMI of three days, which was shorter that the average PMI of 4-
5 days for all cases included in the study. Even more interesting was the fact that the remaining two 
CMV positive cases had PMIs of nine and 14 days respectively. After further investigation, the cause 
of death in one case was found to be CMV nephritis. The most plausible explanation for this sample 
being positive for CMV despite the long PMI is that there could have been a high CMV viral load in 
the tissue sample.  Another issue to consider is the fact that CMV tends to become latent and the 
effect of the PMI has not been evaluated in latent CMV infection. 
The second CMV positive case has a PMI of 14 days and had a diagnosis of bronchiolitis and again 
there might have been a high viral load that could have contributed to the infant’s bronchiolitis and 
eventual death. This is consistent with a study on a previously healthy, 37-day old Asian male infant 
who died as a result of bronchiolitis obliterans, a lung disease that is a result of severe infection of 
the lower respiratory tract. In this specific case, CMV was the viral agent responsible for the condition 
that led to the infant dying (Byun et al., 2014). 
However, the viral load was not tested quantitatively in either of the two cases and CMV is not 
included in the commercial Multiplex PCR assay used in the study. As such, direct comparison was 
not possible. This is a field of future research. 
5.4 Routine microbiology  
Many different species of bacteria are detected during medico-legal SUDI case investigations. 
Bacteria, such as Staph aureus, Haemophilus influenzae, Strep pneumoniae and Strep pyogenes, were 
often detected in sudden infant death investigations and reported in the literature (Forsyth, 1999). 
However, this was not the case in this study as the most frequently encountered bacteria were E.coli, 
Klebsiella pneumoniae, Haemophilus influenzae, Enterococcus faecalis and Strep pneumoniae. The 
significance and interpretation of bacteria detected during SUDI case investigations are extremely 
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challenging, as some of these bacteria are regarded as PM contaminants. A clear histological picture 
showing bacterial infection is required to confirm a bacterial COD. An in vitro study to assess the 
cytokine responses of male and female PBMCs to a bacterial antigen showed a comparatively lower 
production of pro-inflammatory cytokines by male than female PBMCs. This inability to produce 
sufficient cytokines against a bacterial antigen could also partly explain why male infants are at a 
higher risk of death in SUDI due to vulnerability to infection (Moscovis et al., 2014). 
5.5 Multiplex PCR  
When forensic pathologists were defining the COD classifications, they were blinded to the multiplex 
PCR results. As a result, 20 cases had a COD classification of SIDS, although respiratory viruses 
were detected in these cases. Co-infections with two or three different viruses were present in these 
cases. This emphasises the importance of adding ancillary tests, such as multiplex PCR, in 
investigating SUDI cases instead of SVCs, which are almost always negative (personal observation). 
Had the multiplex PCR results been available to the forensic pathologists at the time of classifying 
the COD in these 20 cases, some might have been diagnosed as infection and not SIDS. The failure 
to detect hMPV in any of the SUDI cases investigated was unexpected, because hMPV is usually 
implicated in LRTI in infants and children. However, it is possible that none of the infants investigated 
in this study were in fact infected with hMPV prior to or at the time of death. The hMPV positive 
controls utilised in the multiplex PCR were positive on the agarose gel electrophoresis images and as 
such rule out any false negative findings. Co-circulation of RSV and hMPV has been reported in 
literature (Budge et al., 2014). However, despite RSV being identified as a leading cause of 
respiratory infections in infants worldwide, it was detected in only nine of the 183 cases analysed in 
this study. It is therefore postulated that the respiratory samples were collected for this study at a time 
when hMPV and RSV incidences were low and could actually account for the non-detection of hMPV 
in all 183 cases. The seasonality of RSV outbreaks has also been described in literature (Noveroske 
et al., 2016). It is critical to note that the detection of viral nucleic acid alone does not necessarily 
mean that the virus was responsible for the death of the infant. However, with tissue histology and 
addition of immune biomarkers to the investigation process, the interpretation of the multiplex PCR 
results would be easier and the results more valuable to SUDI case COD diagnosis.  
5.6 Immune biomarkers 
According to the analyte-specific standard deviations shown in Table 4.3, there was a lot of variation 
in the levels of the same cytokine in different SUDI cases. This observation was not unexpected, as 
every individual has an immunological profile unique to activities of their immune system. A range 
of symptoms suggestive of a viral respiratory infection, such as a running nose or cold, prior to death 
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in some of these infants could be the reason why there were such differences in the immunological 
profiles. There was however, no significant difference between serum levels of IFN-γ, IL-1α, IL-
1RA, IL-2, IL-4, IL-5, IL-8, IL-10, IL-12p70, IL-23, IP 10 and TNF-α in cases where infection was 
the COD and cases with a SIDS or non-infectious COD. There was also no statistically significant 
difference in the levels of serum IL-1β in infectious deaths and SIDS or other non-infectious deaths. 
However, when serum IL-1β levels were greater than 85 pg/ml, which is the upper reference limit for 
IL-1β, the difference became statistically significant in the group with a COD of infection compared 
to the rest. Being a pro-inflammatory cytokine, IL-1β in excessive amounts could possibly be 
detrimental to the infant. Inflammatory disease and lung damage are seen in situations where there is 
an imbalance of IL-1 and IL-1RA (Arend, 2002). This could partially be the reason why IL-1β serum 
levels become a possible indicator of an infectious death above the normal cut-off level of 85 pg/ml. 
Statistically significant observations were also made for the three immune biomarkers, CRP, IL-6 and 
IL-18, which are all three important biomarkers in the inflammatory process. 
Despite meticulous medico-legal investigations in SUDI cases, the COD still remains unknown in up 
to 80% of cases (Dempers et al., 2016). As such, part of the study was aimed at potentially 
contributing towards more SUDI cases being diagnosed as infection as opposed to a SIDS diagnosis. 
The serum concentrations of CRP and IL-6 were significantly elevated in the serum of SUDI cases 
where infection was confirmed to be the COD compared to cases that were diagnosed as SIDS.  The 
serum levels of CRP could therefore be used as a potential indicator of prior infection in a SUDI case. 
This is in agreement with a study by Uhlin-Hansen in 2001 where elevated CRP levels were shown 
to be a good indicator of a prior inflammatory process. The suitability of CRP for PM investigations 
due to its stability in storage was also demonstrated in this specific study. Evidence of elevated IL-6 
levels has been observed in non-SIDS cases in the literature when compared to SIDS cases (Vege et 
al., 1995). In contrast to CRP and IL-6, levels of IL-18 were significantly reduced in the serum of our 
SUDI cases where infection was confirmed to be the COD compared to cases with a final COD of 
SIDS. IL-18 is responsible for stimulating NK cells to release IFN-γ, an antiviral cytokine. 
Consequently, low levels of serum IL-18 render an individual more susceptible to a viral infection. 
5.7 Strengths of the study 
The study showed that immune biomarkers can be used to supplement the tissue histology picture 
when determining if infection played a role in the events leading to the death of the infant. If adopted, 
the use of immune biomarkers offers a more comprehensive picture of infection instead of solely 
depending on viral and bacterial culture results, which in most instances have a negative result. 
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A panel of immune biomarkers was identified that can be used as potential predictors of infection 
being the reason behind the death of an infant in SUDI cases. 
Testing was conducted on a large number of samples collected over a full one-year period, enabling 
evaluation of several risk factors, including seasonal variation. 
5.8 Weaknesses of the study  
The lack of a control group remains the main weakness of this type of study. If a control group had 
been available, it would have been easier to compare the test cases with normal (control) cases and 
draw conclusions from the differences observed between these two groups. However, ethical 
restrictions prevented the study from incorporating a control group. 
To the best of our knowledge, this was the first study in South Africa to investigate levels of immune 
biomarkers in SUDI cases. As such, there was a paucity of what constituted as normal serum levels 
of these biomarkers in South African infants. Studies on immune biomarkers in SUDI have been done 
in some developed countries and immune biomarker serum levels in these studies were used as 
reference points for our study. However, the inflammatory profiles of infants in those countries may 
not exactly be the same or truly representative of the inflammatory profile of South African infants.  
5.9 Future research  
As earlier indicated, there is a paucity of data on normal levels of serum cytokines in infants. This 
information gap needs to be addressed by conducting such a study in living, healthy infants. Once 
this data is available, it can be accessible to individuals conducting immunological studies involving 
infants. 
In addition, there is a need for investigating the role of viruses in SUDI. Whether use of an assay 
measuring viral load in lung tissue will be possible, needs to be established. If successful, the viral 
load can be correlated with the severity of inflammation observed in tissue and the serum 
immunological profile. 
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CHAPTER 6: CONCLUSION 
This study aimed to characterise the viruses frequently encountered in SUDI case investigations and 
this objective was completed as shown in Table 4.2. All but one (hMPV) of the 15 target respiratory 
viruses were detected in at least one of the 183 SUDI cases included in the study. However, with 
SVC, only a single virus (CMV) was detected and then in only 13 of the cases, further emphasising 
the shortcomings of SVC for viral detection in SUDI case investigations. As stated earlier, the current 
SUDI case investigation protocol at the Tygerberg Medico-Legal Mortuary utilises SVC for routine 
viral screening although results show a very low positive yield compared to multiplex PCR.  
Ideally, an amendment to the institutional investigation protocol to implement the routine use of 
multiplex PCR in place of SVCs when investigating the COD in SUDI cases should be recommended 
and implemented. However, due to the higher costs of multiplex PCR, the use of a custom viral 
detection assay only targeting viruses that are most frequently detected in SUDI case investigations 
would be more suited and applicable. The use of multiplex PCR in these investigations would 
undoubtedly increase the chances of detecting possible viral involvement in the infant’s death and 
more cases that would previously been assigned a COD of SIDS, could be classified as infection-
related deaths. This would further ensure that infectious COD in SUDI is not underestimated and 
underreported. However, more research is necessary to define and validate a custom viral detection 
panel specifically for the South African population. 
Another aim of the study was to determine the value of immune biomarkers as indicators of infection 
and inflammation prior to or at the time of death of an infant. From the study, a panel of three 
biomarkers, CRP, IL-6 and IL-18 were identified for possible use as predictors of infectious COD. 
These markers however need to be further investigated in a different set of SUDI cases if they are to 
be used routinely. More research is needed to further understand the interaction of respiratory viral 
infections with the immune system and how this can be related to the histological picture observed in 
tissue.  
In conclusion, the contribution of respiratory viruses towards SUDI and the resultant immune 
response can no longer be underestimated and this study was able to identify several novel angles to 
investigate the different interactions in this multifactorial condition. 
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ADDENDA 
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A2 Raw data for statistical analysis 
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